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analysis and manuscript writing. The reported intrinsic and ThT fluorescence
measurements and SEM images were collected by Ms. Colina Dutta. Dr. Ashutosh
Tiwari revised the manuscript and is the corresponding author.
Chapter 4 is based on the multi-author article that is currently under preparation. The
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Chapter 5 is based on the multi-author article that is currently under preparation. The
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revised the manuscript and is the corresponding author.
Chapter 6 is based on two multi-author articles that were previously published in
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3, 2173-2184”. The author of this dissertation was responsible for all live cell
fluorescence imaging, cellular uptake, and toxicity measurements. Dr. Jingtuo Zhang did
all synthetic work, NMR study, and spectroscopic analysis. Mr. Cong Li helped to
conducted spectroscopic data collection and Mr. Fei Xie helped to synthesize starting
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manuscript as the corresponding authors.
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Abstract
Proteins are one of the most versatile macromolecules in the biological system. The
function or activity of a protein highly depends on its 3D native structure. However,
under stress, they are at risk of misfolding/aggregation, leading to formation of structures
that can indicate loss of function or gain of toxicity. In severe cases, protein aggregation
can result in many diseases, including neurodegenerative diseases, such as Alzheimer’s,
Parkinson’s, Huntington’s, and amyotrophic lateral sclerosis. Due to the heterogeneous
nature of cellular environment and protein molecules, mechanism of in vivo folding and
related toxicity still remains elusive. To have a better understanding of the cellular
protein aggregations process and subsequent toxicity, we have performed aggregation
studies of proteins with different types of posttranslational modifications, which is critical
to protein’s functional diversity.
In this dissertation, two common types of covalent modification of proteins, i.e.
disulfide reduction and acetylation, were selected. In aggregation studies of two globular
proteins, hen egg white lysozyme and bovine serum albumin (BSA), formation of
amorphous aggregates were observed as a consequence of disulfide bond scrambling. The
structural properties of the observed aggregates were distinct and depended on disulfide
reduction level. In study of amyloid β (Aβ) peptide, the major pathological protein in
Alzheimer’s disease, effect of acetylation of the two lysine (K) positions, K16 and K28,
on protein aggregation were investigated. We observed that acetylation on K16 can
significantly increase hydrophobicity of Aβ and disrupt amyloid fibril formation.
Interestingly, the heterogeneous mixtures of wild type and acetylated peptides displayed
xi

increased cytotoxicity compared to the homogeneous samples. To further understand the
toxicity of protein aggregates, we then compared the cytotoxicity of eleven different
aggregates from lysozyme and BSA, varying in morphology, size, flexibility, and
hydrophobicity. The results suggest that the protein conformational changes in the early
stage of aggregation process are essential for a gain in toxicity. Thy observed toxic
species are structurally flexible, however, no clear correlation was found between
cytotoxicity and hydrophobicity. Considering all the toxicity results of Aβ peptide,
lysozyme, and BSA, we noticed that mixtures of native and modified proteins or
aggregates are usually highly toxic. Therefore, the observed cytotoxicity of different
structures may result from the heterogeneity of samples that are flexible rather than any
defined structure. Further analysis of the toxic conformation would require high
resolution structure determination of different aggregated protein species.

xii

Chapter 1 Background
Proteins are the most versatile macromolecules that are involved in almost all of the
biological processes. Formed from 20 basic building blocks (amino acids), a protein’s
biological function or activity is determined by its well-defined 3D native structure. In
the cellular environment, there are risks for proteins to form wrong structures, which may
result in loss of function, or in some cases, gain of toxicity. Even the proteins that
successfully fold

into

correct

native

structures

are

only

marginally

stable

(thermodynamically) in a very narrow range of physiological conditions. To understand
the remarkable relationship between protein’s structure and function, the folding process
of protein has been studied for more than 50 years. Researchers tried to answer the
questions: How can a protein fold from the 1D sequence code to 3D structure? How can
cells control protein folding? What happens if a protein folds into the wrong structure?
Can we predict folding? Science magazine framed protein folding problem as one of the
125 most important unsolved problems in science1. While the information in this area is
still growing rapidly, protein folding has already grown into a whole field of research. In
the following sections, basics of the protein folding process will be reviewed, including
history of protein folding, the driving forces and factors of protein folding, and problems
caused by misfolded proteins.

1.1 History of protein folding
About a half-century ago, Max Perutz and John Kendrew won the 1962 Nobel Prize
in Chemistry for determining the 3D structure of globular protein at the atomic level2-4.
1

Their work laid the foundation for molecular biological mechanisms of the relationship
between protein function and structure, and became great support to studies on protein
folding. But the story of protein folding actually started 60 years earlier, in 1902, when
Emil Fischer and Franz Hofmeister discovered that proteins were formed from covalently
linked amino acid chains5. By 1911, Henrietta Chick and C. J. Martin discovered the
denaturation process of protein. It was the first time that protein denaturation was
distinguished from aggregation5. In fact, the concept of “protein folding” was not put
forward until 1929 by Hsien Wu. When the denaturation process was believed to be
either dehydration (Robertson, 1925) or hydrolysis (Anson and Mirsky, 1925) of the
protein5, Wu proposed it to be a purely conformational change: during denaturation, the
3D network of the protein chain changed from a “rigid, regular arrangement” to an
“irregular, flexible open chain”6. However, Wu’s hypothesis was not accepted in the field
immediately, because of the limited knowledge of protein structure. Until 1950s,
reversible denaturation was investigated for serum albumin, hemoglobin7, ribonuclease
A8 and many other proteins, which proved Wu’s hypothesis and also demonstrated that
protein folding and denaturation are thermodynamic processes. The free energy change
between the native and denatured states of a protein was discovered7. Shortly thereafter,
Anfinsen established the “thermodynamic hypothesis”, suggesting that proteins exist in
thermodynamic configurational equilibrium, with the folded state representing the global
minimum of configuration energy8.
Even though in the early studies denatured proteins were successfully refolded to
their native structure and restoring the biological activities in test tubes, the investigators
realized that the folding in a test tube was too slow compared to those carried out in cells.
2

In the talk “How to fold Graciously” (1969), Cyrus Levinthal mentioned the astronomical
number of possible configurations of protein, which was later called “Levinthal’s
Paradox”9: for a polypeptide chain of 100 residues, if each amino acids has 3 stable
conformations, there will be total 3100 possible conformations that the protein may fold
into. On that basis, if a protein reached its native structure by sequentially sampling all
the possible conformations, it would take time that is longer than the life span of any
organism in this universe. Therefore Levinthal proposed that in a biological system, there
must be pathways that guide and speed up protein folding to the correct configuration10.
Study of the role of the intracellular environment in protein folding started from
renaturation of ribonuclease11, influenza hemagglutinin12, and bovine pancreatic trypsin
inhibitor (BPTI)13 in isolated microsomal fractions. From the results, it was noticed that
protein folding can be facilitated by certain proteins in the endoplasmic reticulum (ER) in
eukaryotic cells. For example, the protein disulfide isomerase on ER was found to be
involved in folding of proteins which have disulfide bonds13, 14. However folding of large
complex, multi-domain proteins was found much harder than the small single domain
proteins, which can easily form the native fold by themselves. Large proteins can only
fold efficiently in the presence of certain proteins called “molecular chaperones”. The
term molecular chaperones was first used to introduce nucleoplasmin, a protein that
promotes assembly of DNA and histone-histone interactions without itself being part of
the nucleosome15. Later it was applied to represent families of proteins that facilitate
protein folding, assembly and translocation in bacterial and eukaryotic systems16. To date,
molecular chaperones define a variety of factors that assist generation of native structures
of biomolecules including proteins and nucleic acids7.
3

It has been more than a century since the first exploration of Fischer and Hofmeister,
but the study of protein folding never stopped. Even though there is no specific
commercial target in this field, protein folding has drawn intense interest as one of the
frontiers in science today. Knowledge of protein folding is building from research in
bench-top experiments and computational simulations. Now there are over 100,000
protein structures at atomic detail available on databases like Protein Data Bank (PDB,
www.rcsb.org/pdb)17, and the number keeps growing every year. With the advances in
modern technologies, achievement of protein folding problems can be made not only
through the professional supercomputers18, but also millions of normal home computer
users through Folding@home (folding.stanford.edu)19, or even through a multiplayer
online video game called Foldit (Fold.it/portal)20. Moreover, studies of protein folding,
and misfolding, sheds lights on a whole new class of disease, protein-misfolding diseases,
including Alzheimer’s, Parkinson’s, and type II diabetes. However, to answer the
questions arisen 100 years ago, there is still a long way to go. In the following parts,
fundamentals of protein folding and aggregation process will be discussed in detail.

1.2 Physical forces in protein folding
One of the very first questions asked in protein folding studies is: how can protein
form its 3D structure from its 1D amino acid sequence? Researchers used to propose the
major folding force as electrostatic interactions5, hydrogen bonding21 or hydrophobic
interactions. However since the stability difference between the native and denatured
states of a protein is only 5-10 kcal/mol22, even minuscule interactions may contribute
significantly. All the interactions are important. After years of studies, the common
4

physical forces involved in protein folding5 appear to be electrostatic interaction,
hydrogen bonding, van de waals interaction, hydrophobic interaction, intrinsic
propensities, and chain entropy.

Figure 1.1. Examples of molecular interactions that stabilize protein structures.
1.2.1

Electrostatic interaction

As acids and bases were the earliest denaturants used in protein denaturation studies,
electrostatic interactions were first hypothesized to be the folding force5. In 1924,
Linderstrom-Lang came up with the first quantitative model of electrostatic interactions
on native proteins. Electrostatic interaction, or in another word, ionic bonds, exist
between oppositely charged residues (also called salt bridge) or between salts and
5

charged protein side chains (see example of electrostatic interactions in figure 1.1). The
interactions between protein and ions in solution can destabilize protein by causing
nonspecific repulsions. In detail, one can increase protein net charge by adding acid or
base in the solution. As density of the same charge increases in a tightly-folded protein
molecule, the charge repulsion will force the structure to loosen. This is known as
classical electrostatic effect. However, in contrast, the specific charge interactions, or salt
bridge, between oppositely charged side chains could stabilize the folded structure,
because such interactions only occur in close spatial proximity. During the 1930s, ionic
bonds between protein side chains were believed to be the major contributor to stability
and driving force of folding23-25. More studies on protein structures showed that ionic
bond indeed affect stability26, 27, bus since most charge residues are concentrated on the
protein surface, it’s not the dominant force of protein folding. Jacobsen and LinderstromLang proved the first evidence that if driven by ion pairing, folding would result in a
negative volume change, which is in contrast to experimental results28. Investigation also
showed that proteins have little dependence on pH (near neutral) or ionic strength (at low
concentration) near their most stable pH29. Actually, the free energy contribution of ionic
bonds to total stability was later proved 5-10-fold smaller than hydrophobic interactions5.
In average, there are only about 5 salt bridges per 150 residues in protein, involving less
than 10% of the protein molecule30, which is unlikely to be the dominant folding force.
1.2.2

Hydrogen bonding

The hydrogen bonds are defined as attractive interactions between a hydrogen atom
(or a molecular fragment X–H in which X is more electronegative than H) and an
electronegative atom/group of atoms (See example of hydrogen bond in Figure 1.1). In
6

the 1930s, Pauling proposed the importance of hydrogen bonds in molecules24, and based
on hydrogen bonding patterns, he successfully predicted the model of secondary
structures, α-helix and β-sheets31. It was soon investigated that hydrogen bonds among
amid and carbonyl groups on the backbone is the principle driving force for α-helix and
β-sheets from random coil structure32-34, and the force increased with more polar groups
in the protein. Since helices and sheets are common features in proteins, hydrogen
bonding should naturally play an important role in folding. There are about 90% of C=O
groups and NH groups in proteins form hydrogen bonds to either water molecules,
protein backbone, or other side chains35. Remarkably, all possible hydrogen bonds are
generally satisfied in protein native fold36. Studies on tyrosyl-tRNA synthetase37 and
phage-T4 lysozyme38,

39

found that hydrogen bonds stabilized protein structures.

However, all proteins share the same peptide bond connections to form the backbone, but
the native folded configurations are all different. Thus, the hydrogen bonding interactions
that majorly from the backbone atoms are not specific for a protein to fold into a unique
structure. Kauzmann40 concluded that the intrachain hydrogen bonds have similar free
energy in both folded and unfolded states, suggesting that folding is not favored for
hydrogen bonds formation. In addition, hydrogen bond angles in protein share the same
distribution with those in small molecular compounds35. The hydrogen bond turns out to
be a weak folding driving force, but contributes significantly to the internal organization
in the folded protein5.
1.2.3

Van der Waals interactions

Van der Waals interactions represent the attractions among fixed or induced dipoles5.
Since a folded protein molecule is tightly packed, attractive or repulsive forces between
7

closely arranged atoms are important. In general, for the large numbers of van der Waals
interactions from protein backbone, folding is favored. However van der Waals
interaction is naturally not selective, which cannot count for why there is only one
specific native conformation of the polypeptide chain.
1.2.4

Hydrophobic interaction

Hydrophobic interaction was actually first discovered in the study of electrostatics
forces in protein folding. In early studies, it was noticed that both the processes of folding
and transferring nonpolar compounds from water into nonpolar solutions involved a
significant decrease of heat capacity. In work of Jacobsen and Linderstron-Lang28,
protein folding was driven by the “aversion” from the nonpolar residues to water, the
same force drives micelle formation. While in nonpolar solvent, proteins are easily
denatured. This kind of interaction was first considered as van der Waals41; till 1960s,
Kauzmann and other researchers brought the name hydrophobic bond (earlier called
“antihydrogen bond”), which is now used to describe the relation between hydrophobes
(low water soluble molecules) surrounded by water5. Thus, it is also called “water
mediated hydrophobic interaction”. As more crystal structures of proteins become
available, a core structure formed by nonpolar residues protected from water was found
as a predominant feature of globular proteins42. The compact arrangement of hydrophobic
core helps proteins to reduce the surface area and decrease undesirable interactions with
water molecules. Compared to other types of interactions, the hydrophobic core residues
are more strongly conserved and correlated with the structure43-46. In addition,
substitution of nonpolar residues turned to be more disruptive to protein stability than
other types of substitution47, 48. Therefore, hydrophobic interactions among the nonpolar
8

sidechains from core residues are considered one of the major folding forces. However,
without other interactions, hydrophobic interaction alone still cannot fold protein into
unique native conformation.
1.2.5

Intrinsic propensities

Instead of describing a single type of force, intrinsic propensity represents certain
types of configurations preferred by the peptide chains, depending on size or sequence,
which could be results of the total local interactions among residues5. For example, the
stability of the helix structure increased with length of the polypeptide chain49, 50, in
which the small free energy contribution from each residue summed to become a strong
force what favors helix formation. Globular proteins have unique internal organizations
as combination of helix, sheets, and turns, determined by amino acid sequence. Among
all the attempts to predict protein structures using only intrinsic propensities, the success
rate is ~ 60%, which will be higher within in a given family of proteins51-53. Polymer
chains, not only proteins, share a similar tendency to fold. When a chain molecule forms
self-contact, it will prefer to form a loop as small as possible, which leaves more
accessible conformations for the main chain54. For the same reason, if the chain is to form
a second self-contact, it will be as close as possible to the first structure in the sequence.
As a consequence, when a chain becomes more and more compact, a considerable
number of secondary structures will be developed54. This is not to say that other forces
are not important. This is only to say that intrinsic propensities of a protein chain also
limits the possible conformations when it folds.

9

1.2.6

Chain entropy – principle opposing force

Entropy is the main force opposing folding, in another word, unfolding5, 24. As a long
polymer, the polypeptide chain can gain entropy in many possible configurations,
depending on the relevant degree of freedom. While changing conformation, the
arrangement of connected residues would be affected, including changing specific ion
pairs, or the bond φ, ψ, and χ angles. Entropies that arise from these local configuration
changes are called local entropy. These local entropies resemble translational, vibrational,
and rotational entropies of small molecules55, being independent from the global
properties of the protein, like size or distributions of polar/nonpolar residues5. Although
local entropy is normally small, there are evidences that local entropy could affect protein
stabilities56. There is another type of entropy, nonlocal entropy, arises from “excluded
volume”, which means one part of a long chain cannot occupy the space that was already
occupied by the other part of the same chain. If there is no limitation of volume, a chain
can occupy any large space with any configuration. However, the excluded volume
reduces the ways the polypeptide chain can configure. Recent structure simulation
achievement showed that as a compact polymer, the protein reaches its internal
architecture more as a consequence of steric constraints54,

57

, which has presumably

hydrophobic interaction as the driving force, and nonlocal entropy as the opposing force.
The external thermodynamic conditions, such as pH, temperature, and ionic strength of
the solution can affect the radius and conformations of the denatured proteins, and
therefore the nonlocal entropies. In general, the excluded volume effect is proportional to
the number of residues. Larger proteins have relatively smaller free volume. In this light,
cross-links were introduced to increase protein stability. Evidences showed that after
10

adding cross-link residues, which reduces the number of accessible configurations, the
unfolded state became less favored58, 59. It appears that the most commonly used protein
cross-link is disulfide bonds, which will be discussed in section 1.5.1.

1.3 Energy landscape – A global overview of protein energy surfaces
With a tremendous amount of experimentation achievements on the physical forces
of protein folding, using statistical ideas, the theory of funnel-shaped protein folding
energy landscape was emerged in the late 1980s60-62. The energy landscape is the
mathematical description of the relationship between folding forces and chain entropy
(the major opposing force), as introduced in the last section. It has generally been based
on the assumption that protein folding occurs by searching through an ensemble of
accessible configurations, rather than directly through certain defined structure
intermediates. Since the unstable denatured proteins are conformationally heterogeneous,
in all different types of energy landscape models, proteins always have many high energy
states and only a few low energy states, resulting in a funnel shape. Figure 1.2 shows the
most realistic model, a rugged energy landscape with kinetic traps that proteins can
transiently reside60, 62. With no pathway but multiple folding routes at different conditions
a protein starts folding from the unstable high energy states, crossing substantial kinetic
barriers, toward the low energy native structure. As protein stability increases (lower
energy), conformational entropy decreases63. In this way, the funnel-shaped model
describes protein’s conformational heterogeneity.

11

Figure 1.2. A classic rugged model of protein folding energy landscape (modified
from Onuchic, Annu. Rev. Phys. Chem. 199760 Copyright © 2015 Annual Reviews).
Energy represents the solvent-averaged energy, and the fraction of native-like contacts,
is used to describe the position of a state during folding.
Usually, small single domain proteins, less than 100 amino acids, have relatively
smooth folding funnels. However about 90% proteins in the cell are larger than 100
12

amino acids, which have a strong tendency to form compact structures in aqueous solvent
via hydrophobic collapse64. In those cases, the rapid folded states may not relate to the
correct folding pathway, but there probably are substantial elements of native structures
contained in such species (Figure 1.2, unrelated structures). Structure reorganization that
may involve a high free-energy barrier is then required to convert the rapid folded
structures to the correct fold, resulting in population of intermediate states (Figure 1.2),
which may only have <50% structure similarity to native-like structures65. By limiting the
accessible configurations, intermediates could assist folding on the correct pathway66. On
the other hand, if the intermediates cannot reach native state through the structural
reorganization process, the intermediates are then defined “off-pathway”67. Abundant
evidences had been found that off-pathway intermediates lead to formation of misfolded
structures or aggregates68. Figure 1.3 shows a schematic energy landscape of protein
aggregation, with some common misfolded protein aggregate species, including
oligomers, amorphous aggregates, and amyloid fibrils. Although the native fold and
aggregates appear as very distinct structures, they share the same physical folding forces:
hydrophobic interactions, hydrogen bonding, and many other interactions as introduced
in section 1.2. Since native protein molecules need to keep certain conformation
flexibility to fulfill their biological functions, the native states are only marginally stable
compared to the denatured state. However, as intermolecular assemblies without
biological activities, the protein aggregates are more thermodynamically stable than the
native state of single molecules, showing much lower free energy and less structural
entropy on energy landscape (Figure 1.3). Therefore, the off-pathway aggregation
processes are more kinetically trapped through formation of misfolded proteins or
13

aggregation nucleus by local unfolding events. Next section will focus on different types
of protein aggregates and the different mechanisms by which all manages/removes these
aggregates.

Figure 1.3. Schematic energy landscape for protein folding and aggregation
(modified from Hartl and Hayer-Hartl. Nat. Struct. Mol. Biol. 200969). The light gray
shaded folding part shows the typical on-pathway folding funnel that unfolded proteins
funneling towards the native state via different intermediate states. While the dark gray
shaded part describes the off-pathway aggregation process of unfolded proteins toward
the thermodynamic global free energy minimum form, the amyloid fibrils, via conversion
from kinetically stabilized globular structures, such as oligomers, or amorphous
aggregates.
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1.4 Misfolded proteins
Cells have a protein quality control system that is formed by a large machinery of
proteins, to ensure correct folding and rapid degradation of any mutated or misfolded
protein structures. Irreversibly misfolded and aggregated proteins are normally removed
by ubiquitin-proteasome system (UPS) and autophagy system. However, even after
escaping the cellular quality control machinery, the folded proteins may still form
aggregation intermediates, which can be induced by random conformational fluctuations
or environmental factors. When misfolded proteins cannot be degraded, they may
accumulate inside cells or tissues in form of distinct aggregates. Some of them may form
structures that are toxic and are known to be associated with diseases, such as
amyloidosis, Prion disease, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral
sclerosis, and Huntington’s disease (Table 1.1). Even for proteins that do not cause
amyloidosis, their aggregates can cause toxicity as well70, 71. Especially in age-related
amyloidosis, protein quality control machinery could be saturated by large numbers of
partially folded or misfolded proteins, which keep accumulating in the crowded cellular
environment and eventually form intracellular aggregates before being refolded or
degraded72. In this section, the major pathologic protein aggregates, amyloid fibril,
protofibrils, oligomers, and amorphous aggregates will be highlighted.
1.4.1

Amyloid fibrils

Amyloid fibrils are a specific class of abnormal extracellular protein assembly with
long branchless fiber structures and are resistant to degradation (Figure 1.4). The amyloid
fibril structures were first found about 100 years ago by Dr. Alois Alzheimer, in brains of
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patients diagnosed with dementia. Now amyloid fibrils have been found in many diseases
affecting almost all the organs in the human body, formed by more than 30 plasma
proteins (Table 1.1). Diseases such as Alzheimer’s, type II diabetes, spongiform
encephalopathies, and amyotrophic lateral sclerosis that pathologically associate with
amyloid fibrils are classified as amyloidosis diseases. Recently, the biological function,
instead of pathologic effects, of the amyloid has also been identified73.

Figure 1.4. Different types of amyloid fibrils and pre-fibril intermediates imaged by
transmitted electron microscope (TEM). (a, b) Amyloid β peptide 1-40 (Aβ1–40) fibrils
with (a) ″twisted and (b) ″striated ribbon morphologies. (c) Islet amyloid polypeptide
(amylin) fibrils. (d, e) PrP fibrils with (d) ″R″ and (e) ″S″ morphologies. (f) Pmel17
repeat domain fibrils (g) Aβ1–40 (E22G) protofibrils. (h) Aβ1–40 (E22G) amyloid pores.
Scale bars in (a)-(g) are 200 nm, in (h) is 50 nm. Images are reprinted with permission
from Tycko et al. 201374. Copyright © 2015 American Chemical Society.
Table 1.1. Some human amyloidogenesis proteins and the related diseases75.
Protein name

Amyloid diseases
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# of
S-S

Structure

Androgen receptor
Amyloid-β
α-synuclein
Huntingtin exon 1
Tau protein
Ataxin-1
Calcitonin
Islet amyloid
polypeptide (IAPP)
Prion
Tansthyretin
Abri

Spinal and bulbar
muscular atrophy
Alzheimer's disease
Parkinson's disease
Alzheimer's disease
Huntington Disease
Frontotemporal
dementias
Spinocerebellar ataxia
Medullary Carcinoma of
the Thyroid
Type 2 diabetes
Spongiform
encephalopathies
Senile systemic
amyloidosis
Familial British
dementia
Amyotrophic lateral

dismutase 1

sclerosis

Ig light chains
Gelsolin
Atrial natriuretic
factor
Cystatin C

Haemodialysis-related
amyloidosis
Primary systemic
amyloidosis
Finnish-type familial
amyloidosis

terminal
Natively unfolded

0

Natively unfolded

0

Natively unfolded

0

Probably natively unfolded

0

Probably natively unfolded

1

Natively unfolded

1

Natively unfolded
unfolded (N-terminal) and
α-helical (C-terminal)

1

Predominantly β-sheet

1

Predominantly β-strand

1

Predominantly β-strand

1

β-sheet

1

β-sheet

1

Globular protein

Atrial amyloidosis

1

Hereditary cystatin c

2
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α-helical with unfolded N-

0

1

Superoxide

β2-Microglobulin

0

Globular protein
Globular protein

amyloid angiopathy
Insulin
Lysozyme
Fibrinogen

Injection-localized
amyloidosis
Hereditary systemic
amyloidosis
Hereditary renal
amyloidosis

3

Globular protein

4

Globular protein
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β-sheet

The insoluble amyloid fibrils are structurally dominated by antiparallel β-sheet
structures. Remarkably, the precursor proteins of amyloid fibrils are structurally diverse
and share nearly no sequence similarity, ranging from < 5 kDa small peptide (amyloid βpeptide) to >55 kDa large protein assemblies [transthyretin (TTR)]67,

74

. More

intriguingly, there are many more proteins that do not associate with amyloidosis can
aggregate into amyloid fibril structures under laboratory conditions76, strongly suggesting
that polypeptide chain forms cross-β structures as an inherent property77. Therefore, study
of fibrillization mechanism of one single protein may cast important insights on the fibril
formation process of all proteins.
Amyloid fibrils are normally formed from soluble proteins. Taking nonamyloidogenic globular proteins as an example, fibrils typically form under extreme pH
or temperature conditions, or with denaturant, which destabilize the protein’s native
structure into flexible unfolded or partially folded conformations78. The typical amyloid
formation for lysozyme is at pH 2.0, 65 oC, at high protein concentration79, 80. Other
factors such as mutations were shown to significantly destabilize structures, leading to
increased tendency for fibril formation. The early onset familial Alzheimer’s disease was
found to be closely related to certain Aβ mutations, including Dutch (E22Q), Italian
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(E22K), Tottori (D7N), Flemish (A21G), and Iowa (D23N)81-83. For some proteins,
increase in concentration of native proteins can also result in onset of amyloid disease.
For example, high serum concentration (~60-fold higher than normal) of β2microglobulin can decrease the stability of monomeric proteins and lead to renal
impairment67. While for the proteins that are intrinsically unstructured/disordered, such as
amyloid β-peptides, α-synuclein, partial folding is the critical first step in assembly84.
However, the exact amyloid precursor structure of any protein has not yet been identified,
leaving folding and aggregation disconnected.
Studies of amyloid fibrils started since amyloid deposition was found as a key
character of amyloidosis diseases. However, the question now becomes when do amyloid
fibrils form, before or after the disease occurred? According to the amyloid cascade
hypothesis85, the amyloid precursor protein (APP) initiates the pathogenesis of
Alzheimer’s disease when the protein’s metabolism is altered. As a consequence of
disease conditions, Aβ aggregates into fibrils and form neuritic plaques, which may
further cause neuronal cell loss and that may result in dementia. However, it is the
concentration of soluble Aβ monomers, but not the density of amyloid plaques that
correlate with cognitive impairments86-88. Using electron microscopy and atomic force
microscopy techniques, several pre-fibril intermediate structures, such as protofibrils,
small oligomers, and membrane embedded pores (Figure 1.4) have been identified. These
intermediates could be either on the fibril pathway or off-pathway, which may end up as
amorphous aggregates. Remarkably, the pre-fibril intermediates, especially small
oligomers, were found to be more toxic than mature fibrils, becoming the major
pathologic structures in amyloidosis diseases. Thus, formation of mature fibrils may
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serve a protective role by reducing the population of toxic intermediates89. Therefore, the
research of amyloid fibrils is trying to answer the two questions: (1) what is the atomic
structure of the toxic intermediate species; (2) what is the toxic mechanism.
1.4.2

Amorphous/unstructured protein aggregates

There are many other structures of protein aggregates that are very different than
amyloid fibril structures and all are called amorphous aggregates (Figure 1.5).
Amorphous aggregates are frequently observed during protein expression and
purification, coupled with protein denaturation, when more hydrophobic areas are
exposed on the unfolded conformations. These aggregates are often in a granular
appearance without ordered intermolecular interactions, formed from random assembly
of monomers, or through intermediates like oligomers or protofibrils90. Amyloidogenic
proteins also form amorphous aggregates, when they failed to form amyloid fibrils.
However, in contrast with amyloid fibrils, we know very little about amorphous
aggregates. Due to the high structural flexibility and heterogeneity, it is extremely hard to
measure structures of amorphous aggregates at the atomic level and classify them.
Various amorphous aggregates have been identified recently with different structure
properties and toxicity levels. In many studies, formation of amorphous aggregates was
considered as a sign of successful inhibition of amyloid fibril formation91-93. However,
some amorphous aggregates also associate with diseases, for example, the amorphous
aggregates formed from α-crystallin in cataracts94. Moreover, some amyloid plaques in
amyloidosis are mixtures of amyloid fibrils and amorphous aggregates95,

96

. Since

amorphous aggregates share a lot of structural similarity with intermediate oligomers and
protofibrils, which were recently found to be the most toxic species in human
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amyloidosis, it will be crucial to increase our understanding of the aggregation and
toxicity mechanism of amorphous aggregates. Considering that the normal function of
proteins directly relate to structure, the toxicity of misfolded protein assembly may also
be controlled by certain structure properties. In this light, studies of amorphous
aggregates could benefit understanding of other species in protein folding and
fibrillization as well.

Figure 1.5. Four different amorphous aggregate structures formed from hen egg
white lysozyme, imaged by scanning electron microscope (SEM). (a) Lysozyme (40 μM)
with 10 mM DTT at pH 7.2, 37 oC. (b) Lysozyme (40 μM) seeded by aggregates showed
in (a) at pH 7.2, 37 oC. (c) Lysozyme (700 μM) at pH 7.4, 65 oC. (d) Lysozyme (120 μM)
at pH 12.0, 25 oC. All scale bars = 1 μm. Images (a) and (b) are reprinted with permission
from Yang et al. 201597 Copyright © 2015 American Chemical Society.

1.5 In vivo factors of protein folding and aggregation
While a variety of conditions that direct correct folding have been successfully
developed, there are still differences between folding processed in cell compared to those
in a test tube. Taking hCG-β subunit14 and tail spike protein P2298 as examples, the in
vitro folding processes appeared to parallel their intracellular assembly, proceeding
through the same folding intermediates to the same final native fold, but the in vitro
folding rates and efficiency were much lower. On the other hand, small proteins can fold
within microseconds into the native structures in diluted buffer solutions; however, the
21

same process may take minutes even hours to large, multidomain proteins. Knowing the
highly crowded cellular environment normally contains 300-400 g/l99 cytosolic proteins,
efficient correct folding of large proteins in cells is more challenging. The entire folding
process is, thus, assisted and controlled by molecular chaperones, which are also widely
applied to in vitro conditions to assist folding7. Most chaperones that participate in
protein folding are multicomponent molecular machines that typically recognize and bind
to the hydrophobic regions of a polypeptide chain or non-native proteins. This protects
the hydrophobic patches from random interactions and aggregation, and at the same time,
may also lead to conformational rearrangements to remove kinetic barriers in folding100.
When released from chaperones, the hydrophobic residues can collapse rapidly (nano- to
few microseconds) forming the core. Normally small proteins reach partially folded
structures after fast folding and can then rapidly fold into the native states. Whereas the
longer chains that require more time to fold will bind to the chaperone again and undergo
another cycle99. Proteins that are not able to accomplish folding through fast-folding
trajectories will be transferred to the chaperonin cages, which are 800-900 kDa protein
complexes that are specialized to assist folding of large proteins, such as actin and
tubulins101.
In the cells, most eukaryotic membrane or secreted proteins follow a similar route:
First, the nascent proteins are synthesized in rough ER. Then, they are translocated to the
cisternae of ER, where (1) signal peptide is cleaved; (2) secondary structures and/or
tertiary structure form as a result of co-translational folding; (3) posttranslational
modifications takes place; and (4) disulfide bonds are formed. Finally, proteins are
transferred to the Golgi apparatus or cell surface. This section will focus on disulfide
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bonds and posttranslational modifications, which play important but distinct roles in
protein folding and aggregation.
1.5.1

Disulfide bonds in proteins

A favorable redox potential is required in many folding systems to assist disulfide
bond formation, which is important for proteins to maintain the ordered structures.
Disulfide bonds, the reversible covalent linkages between the side-chain β-thiol groups of
cysteine (C) residues, are by far the second most common covalent bond in proteins and
peptides102. They are naturally formed in 65% of secreted proteins and more than half of
amyloidogenic proteins (Table 1.1)75. Moreover, disulfide bonds exist in folded proteins
as well as the unfolded ones (see examples in Table 1.1). However, the link between
disulfide bonds and aggregate/amyloid formation is still a matter of debate. Some native
disulfide bonds help to prevent aggregation or fibrillization. In general, hydrophobic
residues are mostly buried inside the core structure with native disulfide bonds103.
Therefore, disruption of native disulfide bonds can result in exposure of hydrophobic
structures, which may lead to protein aggregation. For example, the only disulfide bond
in human cellular prion protein (PrP), C179-C214, is buried in the hydrophobic core,
contributing to stabilize the globular structure104 and does not exist in the pathological
scrapie PrP. Instead, the pathological scrapie PrP forms intermolecular disulfide bonds.
Evidences showed that the scrapie PrP polymers can convert monomers of normal
cellular PrP into scrapie-like conformation through disulfide exchange75 (Figure 1.6).
Reduction of disulfide bond increases the protein conformational flexibility, which can
assist conversion of the native α-helix structure into β-sheets and then form amyloid
fibrils105. In addition, cleavage of the disulfide bond not only promotes conversion of
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scrapie PrP, but also leads to dramatic conformational change and exposure of interior
structures of the protein, which enhances in PrP-membrane interaction, alters cell
physiology, and finally causes cell death. Furthermore, reduction of native intramolecular
disulfide bonds leads to protein disulfide cross-linking or self-assembly, results in
fibrillation. This has been shown for many amyloid proteins75, 105, 106.

Figure 1.6. The transformation of cellular PrP (PrPc) to the pathological scrapie PrP
(PrPsc) polymer.* The breakage of intramolecular disulfide bonds of PrPc can be initiated
by free thiol group on PrPsc by forming intermolecular disulfide cross-linking and is
followed by conformational change of PrPc. When the conversion is completed, the
newly formed polymer starts another cycle. *Adapted from Li et al. 201375
In some other proteins, the native disulfide bonds are essential to amyloid fibril
formation. The β2-microglobulin (β2M) has one fully buried intra-chain disulfide bond,
which significantly contributes to amyloid fibril formation rather than stabilizing the
native fold107,

108

. Another example could be amyloidogenic peptide Abri, which

predominantly has β-strands with one intramolecular disulfide bond (Table 1.1). In
solution, the disulfide bond on Abri peptide promotes rapid formation of oligomers and
the highly insoluble amyloid deposits in familial British dementia

109

. According to

Abkevich and Shakhnovich110, folding could be directly affected by the relative position
of disulfide bonds, meaning that if the disulfides located in or near folding/aggregation
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nucleus, they may guide the process, whereas those located far form the nucleus
structures may slow down the progresses110.
Since natural protein/peptide with disulfide bonds have more constrained
frameworks and higher stabilities than other biomolecules, intermolecular disulfide crosslinking have attracted the attention of protein engineering. Hundreds of peptide-based
drugs design and valuable scaffolds in tissue engineering are based on the discovery of
natural disulfide-rich architectures111. Furthermore, some disulfide-rich peptides were
also applied to solve the oral delivery and cell uptake issues in pharmacology. One such
example is application of the cell-penetrating peptides (CPPs)112 in drug delivery
platforms. CPPs are short, water-soluble peptides that are capable of crossing cell
membranes and even the blood-brain barrier. Since the intracellular glutathione
concentration is ~ 1000-fold higher than those in the extracellular environment, disulfide
moieties are widely used for building CPP-drug conjugates113. In this light, the CPPconjugates are stable during transfer in the tissues, but once the conjugates crosses the
cell membrane, the elevated thiol concentration breaks disulfide bonds and leads to
release of the cargo drug114. This approach of CPP has been successfully applied in drug
delivery field and may bring a large number of peptide drugs into the market,
contributing to both academic and industrial worlds111.
1.5.2

Posttranslational modifications in proteins

There are approximately 30,000 protein coding genes in human genome, but the
actual number of cellular protein species in cells are more than one million. This
diversification of protein first expands by mRNA splicing at the transcriptional level,
which is a central topic of RNA metabolism115 and will not be discussed here. The second
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proteome expansion route is the specific enzyme-catalyzed covalent posttranslational
modification (PTM) on the side chain or backbones of nascent or folded proteins.
Depending on the targeting amino acid side chains, the modifying enzyme, and the
reversibility of the reaction, the major types of protein covalent modifications can be
classified as phosphorylation, acetylation, methylation, ubiquitination, and glycosylation
(Table 1.2). Other chemical events such as disulfide formation (discussed in section 1.2),
backbone cleavage, proteasome autoactivation, and green fluorescent protein maturation
are also considered as PTMs.
Table 1.2. Posttranslational modifications on protein side chains102.
Residue

Reaction

Arginine

N-methylation, N-ADP-ribosylation

Asparagine

N-glycosylation, N-ADP-ribosylation , protein splicing

Aspartic acid

Phosphorylation, Isomerization to isoAsp

Cysteine

S-hydroxylation (S-OH), Disulfide bond formation , Phosphorylation,
S-acylation, S-prenylation, protein splicing

Glutamine

Transglutamination

Glutamic acid Methylation, Carboxylation, Polyglycination, Polyglutamylation
Glycine

C-hydroxylation

Histidine

Aminocarboxypropylation, Phosphorylation, Regulatory systems, Nmethylation

Lysine

N-methylation, N-acylation by acetyl, biotinyl, lipoyl, ubiquityl
groups
C-hydroxylation

Methionine

Oxidation to sulfoxide

Proline

C-hydroxylation

Serine

Phosphorylation,

Phosphatases,

Pphosphopantetheinylation
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O-glycosylation,

Autocleavages
Threonine

Phosphorylation, O-glycosylation

Tryptophan

C-mannosylation

Tyrosine

Phosphorylation, Sulfation, ortho-Nitration, TOPA quinone

The major PTMs covalently add external chemical groups on the protein that alter
the protein’s structure, size, charge, or conformation, and result in changes of
hydrophobicity, biding affinity, enzyme activity, or sometimes create architectural
impetus for molecular signaling. As the most common PTM, phosphorylation introduces
anionic phosphates to the neutral OH side chains of serine, tyrosine, and threonine. The
local microenvironments around these residues are then altered, and as a consequence,
protein conformation changes. Tau is a microtubule associated protein that contains 5
tyrosine and 80 serine/threonine as potential phosphorylation sites. When tau is
abnormally hyper-phosphorylated, it aggregates into paired helical filaments and forms
neurofibrillary tangles, which is identified as a histopathological hallmark in Alzheimer’s
disease116. Similarly, acetylation alters the charge distribution on proteins by blocking the
positively charged lysine side chains with neutral acetyl groups. There are tens of
thousands of glycoprotein variants that are added to at least one third of secretory
proteins by glycosylation, which alters protein architecture during folding or qualitycontrol processes102. A protein can be posttranslationally modified with the same group at
many residues, as the tau protein introduced above, or a protein can also have several
PTMs targeting on the same molecule. For example, histone has a total of 15 lysine
residues on its four tails that organize how DNA is wrapped into nucleosomes. Two PTM
types, acetylation and methylation, compete on the positively charged lysine and arginine
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side chains on histone tails and result in opposite effects on gene transcription. Histone
acetylation leads to loose packing of nucleosomes, which initiates binding of
transcription factors and starts gene expression. Whereas blocking the lysine and arginine
with methyl groups can result in tight packing of nucleosomes, and gene expression is
turned off117. Another PTM, ubiquitination, also competes with acetylation and
methylation on lysine side chains. Unlike the small single acetyl groups in acetylation,
the ubiquityl aceyl moiety links to an 8-kDa protein ubiquitin and functions as a signaling
scaffold that provides information with particular partner proteins during biological
responses. Ubiquitination usually targets the proteins that need to be relocated and
degraded in cells. The partner proteins that contain ubiquitin receptors can act as
chaperones, importing the target protein into early endosomes and then lysosomes for
hydrolytic degradation102.
To date there are more than 300 PTMs that have been discovered with the
advancement of high-resolution mass spectrometry techniques, and the number is still
increasing. It is not surprising that PTMs play an important role in protein folding and
aggregation. The amyloidogenic proteins such as Aβ and tau in Alzheimer’s patients’
brains are recently detected to have various types of glycosylation on the side chains118,
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. Extracellular phosphorylation and N-terminal truncation both result in acceleration of

Aβ assembly, leading to neurotoxic aggregate species120, 121. Therefore, studies of PTMs
can not only give insight into how the bioactive structures have been tuned by nature for
hundreds of thousands of years, they also help us to understand the pathology of diseases.
Moreover, since many PTMs serve as parts of the signaling pathways, they have been
also widely applied as biomarkers or potential therapeutic targets in many diseases122, 123.
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1.6 Motivations and hypothesis
As introduced in section 1.4, in addition to amyloid fibrils, the aggregation
intermediates and amorphous aggregates now draw the biggest question marks in the
field of amyloid diseases. Recent research strongly suggests that the non-fibril oligomers
hold the key of toxicity. Even though several oligomeric structures have been
characterized, there is still no common standard to define a “toxic structure”. In addition,
there are many factors that can affect protein structure in a living cell in spite of great
strides made in the field. The full picture of protein aggregation and its relationship to
toxicity is not clear. Therefore, it is important to characterize and link many different
structural forms of aggregates to toxicity to have a better understanding of the protein
misfolding diseases.
One of the intracellular protein folding factors that can be possibly altered is the
status of disulfide bonds. In the past, most studies on protein disulfide bonds were carried
out at extreme pH or temperature79, 80, 124, while the in vivo environment is relatively mild
in terms of pH and temperature variations. Experiments under conditions close to
physiological (pH 7.2 and 37 oC) may contribute to a better understanding of protein
aggregation process in cells. Besides the high concentration of glutathione in cytosol,
improper use of thiol based antioxidant supplements on a daily basis can also increase the
levels of free thiol groups in the body, resulting in a highly reducing environment in vivo.
The highly reducing environment has potential of breaking protein disulfide bonds.
Therefore, in the first project (chapter 3) we selected a commonly used disulfide reducing
agent, dithiothreitol (DTT), to treat two disulfide rich proteins, hen egg white lysozyme
(Lysozyme) and bovine serum albumin (BSA), near physiological condition. Lysozyme
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is the amyloidogenic protein that has the highest number of native disulfide bonds (4) and
is globular in shape. While BSA is a globular protein with 17 native disulfide bonds but
is not involved with any amyloid disorders. Investigating the effect of disulfide
scrambling (i.e. non-native disulfide formation) on the aggregation process using these
two different types of proteins could give insight into the aggregation pathways that may
be relevant to several other proteins.
The other factor that we investigated was how a PTM, like acetylation on lysine side
chains, can impact protein aggregation. As discussed in chapter 4, we blocked the
positive charge on the two lysine residues of Aβ peptide, K16 and K28, by acetylation.
The Aβ peptide has only 42 amino acids and is an intrinsically disordered structure.
Aggregation of Aβ is simply driven by hydrophobic interactions. Residue K16 is located
at an intermolecular binding region (K16-F20) and the K28 residue is known to form
important intramolecular salt bridges that stabilize the β-sheets in amyloid fibrils.
Therefore, we propose that acetylation on one or both of these two lysine residues could
impact Aβ fibrillization process. How do these acetylation modulate Aβ aggregation may
give insight into therapeutic strategies of Alzheimer’s disease.
Finally, we wanted to focus on the central problem in protein aggregation field, the
relationship between aggregate structure and its toxicity. Unlike the amyloid structure
that is well defined, the structural characteristics of amorphous aggregates are still not
clear. After generating many different types of amorphous aggregates using literature
reported condition, we noticed that the amorphous structures are vatiable. In chapter 5,
amorphous aggregates that were generated at ten different conditions were characterized
and classified in terms of size, hydrophobicity, or structural flexibility. Then these
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aggregates were used to measure cell cytotoxicity. By comparing the cytotoxicity of these
amorphous aggregates, we want to identify the dominant structure that is toxic. Once we
have a good understanding of the structures, the goal is to identify small molecules that
can efficiently bind to these structures and hence can decrease their toxicity. This will
have serious implication for many protein misfolding diseases for developing effective
drug candidates.
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Chapter 2 Methods
Several biochemical and biophysical techniques are employed to investigate protein
folding, misfolding, and aggregation. Table 2.1 shows techniques most frequently used
for protein folding/aggregation research. Each technique listed below has its own strength
and limitations. This chapter will focus on introducing the techniques and experimental
methods used to carry out protein aggregation studies reported in this dissertation. This
includes UV-vis absorbance spectroscopy, fluorescence spectroscopy, non-reducing gel
electrophoresis, scanning electron microscopy, cytotoxicity assays, and live cell
fluorescence imaging. Details of specific experimental conditions are mentioned in each
chapter.
Table 2.1. Some common biophysical methods used to investigate protein folding
and aggregation processes1, 2. U, unfolded or partially folded states; N, native states; O,
Oligomers; A, (amorphous) aggregates; F, amyloid fibrils.
Property

Technique

species

Folding/Aggregation
kinetics

Ultraviolet absorbance

U, N, O, A, F

Intrinsic fluorescence

U, N, O, A, F

ANS fluorescence

U, N, O, A, F

Mass Spectrometry

U, N, O, A, F

Fluorescence resonance energy transfer U, N
(FRET)

Structure

Hydrogen-deuterium exchange

U, N, O, F

X-ray diffraction

N, F
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Far-UV circular dichroism (CD)

U, N, O, A, F

Solution/Solid state NMR

U, N/O, F

Atomic force microscopy (AFM)

O, A, F

Electron microscopy (EM)

O, A, F

Fourier transform infrared spectroscopy U, N, O, A, F
(FTIR)

Conformation

Fluorescence microscopy

A, F

bis-ANS fluorescence

U, N, O

Congo red or Thioflavin T fluorescence

A, F

Analytical ultracentrifugation

U, N, O, F

Calorimetry

U, N

Gel chromatography

U, N, O

2.1 UV-visible absorbance spectroscopy
Spectroscopy technique measures the effect of electromagnetic radiation on
molecules. Light in the near-ultraviolet and visible (UV-vis) range (150-800 nm)
comprises photon energies of about 150–400 kJ/mol3, which are sufficient to excite
electrons to a higher energy orbital. Among the six electronic excitations that may occur
in an organic molecule (Figure 2. 1), the transitions of n or π electrons to the π* state can
be achieved by the energies from UV-vis lights. Therefore, the substances that applied in
spectroscopy analysis normally have delocalized aromatic systems, such as proteins and
nucleic acids. The absorption maxima of proteins is normally near 280 nm, contributed
mainly by the two aromatic amino acids tryptophan (Trp) and tyrosine (Tyr) (Figure 2.
46

2). The absorptivity of phenylalanine (Phe) is 10-fold lower than Tyr and 30-fold lower
than Trp3, thus, Phe normally does not account for protein UV absorbance. For a protein
that contains Trp residues, such as lysozyme, the protein UV absorbance spectra is in the
same shape with Trp UV absorbance spectra. The absorbance measurements of proteins
are usually carried out in aqueous buffer solution, where the protein absorbance is
proportional to its concentration, following the Lambert Beer’s law:
A=ε·c·l
where A is absorbance; ε is the molar extinction coefficient (M-1·cm-1), describing the
light absorption ability of a molecule at certain wavelength; c is molar concentration; and
l is the path length in cm. The UV-vis spectroscopy method is very sensitive and
nondestructive, therefore, it is widely applied in quantitative analysis. Since the changes
in local environment around the chromophores can alter the wavelength of peak
absorbance, absorbance spectroscopy technique is also suited for measurements of
ligand-binding reaction, conformational changes of proteins or nucleic acids, and protein
assembly.
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Figure 2.1. Molecular orbitals.

Figure 2.2. UV-vis absorbance spectrum of amino acids Phe, Tyr, and Trp (A) and
lysozyme (B). (A) UV absorbance spectra of phenylalanine (2.5 mM), tyrosine (0.5 mM),
and tryptophan (0.1 mM) in phosphate buffer (40 mM, pH 7.0). (B) UV absorbance
spectra of lysozyme (D, 21 μM).
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All absorbance measurements in the following chapters were carried out on a Perkin
Elmer Lambda 35 UV/VIS spectrometer. UV-vis absorbance was first used to measure
the concentration of native proteins and fluorescence dyes in stock solutions. We also
carried out UV-vis absorbance measurement to detect the soluble protein level in
aggregation samples. Protein samples were incubated for the indicated time and then
centrifuged at 20,000 × g for 5 minute. The supernatant was collected and diluted to 50%
with 20 mM pH 7.2 sodium phosphate buffer and then absorbance was measured from
240 to 600 nm. All measurements were done in triplicates. Controls were similarly
prepared and incubated as the samples, had all the ingredients as in the sample except
protein, and were used for background subtraction.

2.2 Fluorescence spectroscopy
Fluorescence describes the phenomenon that when electrons are excited from the
ground state to S1 or S2 state, they emit energy in the form of light before returning to
the ground state. Molecules with fluorescence properties are typically aromatic
compounds, called fluorophores. As introduced in last section, electrons in delocalized
aromatic systems can absorb energy from light and be excited to higher energy levels.
However, these electrons are very unstable on the excited orbitals, thus, they rapidly
return to the ground state by release energy as emitting photons. The Jablonski diagram
can be used to illustrate the light absorption and fluorescence emission process (Figure
2.3). The energy levels S0, S1, and S2 represent the ground, first, and second electronic
states, respectively, and each energy level has many vibrational levels. Depending on the
light irradiation energy, the electrons could be excited to different vibrational levels of
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excited states S1 or S2. Soon after that, when the electrons relax to the lowest vibrational
level of S1 via vibrational relaxation from the higher vibrational levels of S1, or through
internal conversion from S2 to S1. These rapid relaxation processes complete within ~10
picoseconds, which usually occur prior to the fluorescence emission and do not involve
photons. The lowest vibrational state of S1 is a thermally equilibrated state. When
electrons return to various vibrational levels of ground states (S0) from S1, energies are
released through emission of photons, which is known as fluorescence. The electrons on
S1 state can also be converted to the triplet states, T1, through intersystem crossing. If
electrons return to S0 from T1, another type of luminescence could be observed, called
phosphorescence. Since T1 is a lower energy level than S1, phosphorescence generally
has longer emission wavelengths and lower emission rates compared to fluorescence.
The chemical structure and local environment of a fluorophore significantly affect
the shape and intensity of its emission spectra, therefore, fluorescence spectroscopy has
been employed as a sensitive analysis method in protein folding studies. In our studies,
two fluorescence methods, protein intrinsic fluorescence and extrinsic fluorescence, were
used to monitor protein structure change during aggregation.
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Figure 2.3. A typical Jablonski diagram. S0, S1, S2, and T1 represent the ground,
first and second electronic states and triplet state. The colored straight arrows represent
the processes that involve photons, including absorption (red), fluorescence (blue), and
phosphorescence (green). The curved arrows represent the radiationless transitions.
2.2.1

Protein intrinsic fluorescence

The protein intrinsic fluorescence is derived majorly from the amino acid Trp and
Tyr. Fluorescence intensities of Trp and Tyr are quite sensitive to the local environment,
roughly correlating with the degree of solvent exposure of these residues. When
transferred from a polar solvent to a non-polar environment, the fluorescence intensities
of Tyr increased while Trp decreased (Figure 2.4 A). The peak wavelength (λmax) of Trp
also shifted from 360 nm to 345 nm from polar to non-polar. This is because that upon
excitation, the electron density at the pyrrole ring will be shifted to the benzene ring4. On
the proteins, same blue shift of tryptophan fluorescence can be observed during folding
when the electron density near pyrrole end is higher than the benzene end due to the
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electric field imposed by other charge residues or the solvent, while the opposite results
in a red shift (to longer wavelengths) of λmax. Therefore, protein intrinsic fluorescence
can provide information of protein conformational changes. Figure 2.4 C shows intrinsic
fluorescence spectrum of lysozyme during chemical denaturation.

When the

concentration of denaturant guanidine HCl (GdnHCl), increases, the protein lysozyme
unfolded and lost the compact native structure. As a consequence, the Trp residues which
are normally buried in the hydrophobic core are exposed to the aqueous buffer
environment during unfolding, resulting in increase of fluorescence intensity and red shift
of λmax.

Figure 2.4. Intrinsic fluorescence of amino acids and protein. (A) Fluorescence
intensity change of Phe, Tyr, and Trp in 0-90% ethanol solutions. Emission peak
intensities at 324 nm of Phe, at 306 nm of Tyr, and at 346-359 nm of Trp were plotted as
function of percentage of ethanol in the solution. (B) Change of fluorescence intensity
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and peak wavelength of Trp in 0-90% ethanol solutions. (C) Intrinsic fluorescence
emission spectra of lysozyme during denaturation by 0 -7 M guanidine HCl (GdnHCl).
Therefore, by monitoring the position change of Trp residues on proteins, intrinsic
fluorescence can sensitively detect protein conformational changes during aggregation.
Fluorescent measurements in the following chapters were all performed on a Horiba
Jobin Yvon spectrofluorometer (Fluoromax-4) at room temperature. For protein intrinsic
fluorescence analysis, samples were diluted with phosphate buffer (20 mM, pH 7.2) or
with HEPES buffer (20 mM, pH 7.2) to a final protein concentration of 10 or 5 μM.
Intrinsic fluorescence spectra were collected from 300-450 nm with excitation at 280 nm.
All measurements were done in triplicates. Bandwidths for excitation and emission were
set at 2 nm. Controls were similarly prepared and incubated as the samples, had all the
ingredients as in the sample except protein, and were used for background subtraction.
2.2.2

Extrinsic fluorescence

In addition of intrinsic fluorescence, the use of various extrinsic fluorescent probes
provides additional possibilities for protein characterization. The extrinsic probes are
normally synthetic chemical fluorophores that usually attach to protein via non-covalent
interactions, including hydrophobic and electrostatic interactions. As introduced in Table
2.1, fluorescence analysis with extrinsic probes can be applied to almost all protein
species generated during aggregation, to detect changes of kinetics, structure, size, and
conformation.
The fluorescent dye 1-anilinonaphthalene-8-sulfonate (ANS, Figure 2.5) is the most
frequently used hydrophobic probe in protein characterization. ANS is very sensitive to
local solvent environments and is very weakly fluorescent in polar (aqueous)
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environment, but shows blue shift of the emission maximum and an increase of
fluorescence in non-polar environment e.g. organic solvents or hydrophobic pockets on
proteins5-7. Therefore, ANS fluorescence can be used to measure protein’s
hydrophobicity. Hydrophobic and electrostatic interactions are believed to be the major
binding mechanisms of ANS to proteins7-9, where electrostatic interactions between the
negatively charged sulfonate group of ANS and the positively charged residues on
proteins play a predominant role7. Complementary interactions like van der Waals also
stabilize the ANS-protein binding5.

C
NH

SO3

ANS

Cl
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O3S

SO3

CH3
N
S

H3C

bis ANS

CH3
N
CH3

ThT

Figure 2.5. Molecular structures of the extrinsic fluorescent dyes used in our protein
aggregation studies.
Interestingly, the dimeric analog of ANS, bis-ANS, does not bind tightly to
organized structures, even though the binding of bis-ANS to protein is dominated by
hydrophobic interactions10. The different sizes of ANS and bis-ANS result in differences
in their binding affinities and the number of binding sites on a protein. Bis-ANS requires
a flexible molten globule like structures for tight binding11,

12

, and reacts weakly to

amyloid fibrils13. Therefore, ANS and bis-ANS provide different information in protein
aggregation measurements. ANS fluorescence measures the aggregation by monitoring
the extent of protein hydrophobicity, which is the major driving force during aggregation.
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Whereas, bis-ANS fluorescence detects how flexible the misfolded hydrophobic
structures is giving insight about the nature of aggregate (i.e. is it lose or compact).
Thioflavin T (ThT, figure 2.5) is a probe that is widely used to characterize and
quantify amyloid fibril structures. With the hydrophobic ring structures, ThT absorption
λmax can be affected by solvent polarity14. However, ThT fluorescence intensity depends
more on viscosity and the rigidity of the microenvironment rather than polarity5. It has
been proposed that when ThT interacts with amyloid fibrils, the steric constraints of
amyloid structures require flat conformation of the dye molecule, which changes the
twisted angle φ of the single bond between benzothiazole and the benzene ring from ~90°
to ~30°, resulting in increase of fluorescent signal at 480 nm15. The binding of ThT to
amyloid fibrils was proposed to occur at the grooves that parallel to the long axis of
fibrils, driven by the hydrophobic interactions with amino acid side chains16. However,
many recent studies found that ThT also binds to non-fibrils structures and generates high
fluorescence17, 18. It was then suggested that hydrophobic structures with cavity of 8-9 Å
in diameter that are capable to bind ThT and generate the character fluorescence peak at
480 nm5,

19

. Therefore, we used ThT fluorescence in the experiments to analyze the

structural detail of aggregates/fibrils.
Fluorescence measurements in the following chapters were all performed on a
Horiba Jobin Yvon spectrofluorometer (Fluoromax-4) at room temperature. Stock
solutions of extrinsic fluorescent dyes were prepared in ethanol, and then freshly diluted
with phosphate buffer (or HEPES buffer for TCEP treated samples) as working stocks at
concentration of 350 μM (ANS), 70 μM (bis-ANS), and 700 μM (ThT) for incubation
with the protein samples. Concentrations of stock solutions were determined by UV-vis
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absorbance using extinction coefficients: ANS ε350 nm = 5,000 M-1cm-1, bis-ANS ε385 nm =
16,790 M-1cm-1, and ThT ε416 nm = 26,620 M-1cm-1. ANS and bis-ANS were used at a
final concentration of 5 μM and 1 μM, respectively, with 15 minute equilibration with 10
μM of proteins in samples on ice. Fluorescence spectra (400-700 nm range) were
collected with excitation at 380 nm for ANS and 360 nm for bis-ANS. For ThT
fluorescence, 10 μM dye was incubated with 5 μM proteins on ice for 30 minutes and
emission spectra (460-700 nm range) were collected with excitation at 450 nm. All
samples containing fluorescent dyes were incubated in dark for the time indicated before
the emission spectra were acquired. All measurements were done in triplicates.
Bandwidths for excitation and emission were set at 2 nm. Controls were similarly
prepared and incubated as the samples, had all the ingredients as in the sample except
proteins, and were used for background subtraction.

2.3 Non-reducing gel electrophoresis
Gel electrophoresis is a technique frequently applied for the separation and
characterization of nucleic acids and proteins in biochemistry and molecular biology
analysis. Based on the principle that the charged particles migrate in solution under the
influence of an electrical field, gel electrophoresis methods can separate molecules by
size, charge, or shape. The polyacrylamide gel electrophoresis (PAGE) is most suitable to
separate proteins ranging in size from 5 to 2,000 kDa, depending on the uniform pore size
of the gel, which can be modulated by the ratio of acrylamide and bis-acrylamide when
casting the gel. In general, smaller protein molecules migrate faster and further than the
large ones, resulting in separated bands on the gel (Figure 2.6). To make sure all the
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proteins that have different net charges move in the same direction on the gel, a
negatively charged detergent, sodium dodecyl sulfate (SDS), is usually added to protein
samples to unfold their 3D structures and add negative net charges on the molecules.
Therefore, on a SDS-PAGE, the migration of proteins is mainly affected by their
molecular weight.

Figure 2.6. Principle of SDS-PAGE. From: BIOCHEMISTRY 8E, by Jeremy M.
Berg, John L. Tymoczko, Gregory, J. Gatto, Lubert Stryer, Copyright © 2015 by W.H.
Freeman and Company. Used by permission of the publisher.
Depending on their stability and structure, proteins may or may not be able to
maintain disulfide bonds intact through boiling with SDS sample buffer. The regular
denaturing SDS-PAGEs usually contain reducing agent DTT or β-mercaptoethanol in the
sample buffer to reduce any disulfide bonds, so electrophoretic mobility of proteins in
SDS-PAGE depends only on size. Whereas in non-reducing SDS-PAGE (Figure 2.7),
sample buffer contains no disulfide reducing agent, that is, proteins could maintain their
intact disulfide bridges during migration through the gel. Since disulfide bridges can
significantly change the tertiary structure of a protein, migration of proteins on nonreducing SDS-PAGE depends on hydrodynamic volume, which is a combination of size
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and shape20. Generally, with disulfide bridges, proteins should have more compact shape
and run faster on a gel. Therefore, when studying the effect of disulfide bonds on protein
aggregation, we decided to use the non-reducing SDS-PAGE, which allows us to analyze
the aggregates formed through intermolecular disulfide linkages.

Figure 2.7. Non-reducing SDS-PAGE. Gel images are reprinted with permission
from Yang et al. 2015. Copyright © 2015 American Chemical Society.
In the non-reducing SDS-PAGE experiment, incubated protein samples were first
mixed with 5 mM iodoacetamide and incubated for 2 h at room temperature to block any
free thiol groups. To terminate the reaction with iodoacetamide, protein samples were
boiled with SDS sample buffer (lacking reducing agent) for 3 minutes. For the fully
reduced samples, freshly prepared 40 μM protein solutions at pH 7.2 (20 mM phosphate
buffer having 150 mM NaCl) were boiled with SDS sample buffer containing 10, 40, or
100 mM DTT or 5% 2-mercaptoethanol for 3 minute. Lysozyme (10 μg/lane) and BSA (5
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μg/lane) samples were loaded on 15% and 10% Criterion Tris-HCl polyacrylamide
precast gels (Bio-Rad), respectively. Tris-glycine-SDS buffer (25 mM Tris, 192 mM
glycine, 0.1% SDS, pH 8.3; Bio-Rad) was used as running buffer and proteins were
separated by SDS-PAGE. The gels were stained with Coomassie blue stain and images
were acquired using an Epson scanner.

2.4 Scanning electron microscopy (SEM)
Instead of light, the electron microscopes use a beam of accelerated electrons as an
illumination source. Since the wavelength of an electron is 105 fold shorter than a photon,
the magnifications of electron microscope can be up to about 10,000,000x, which is
5,000 higher than most light microscopes. The SEM produces images by scanning the
specimen with a focused electron beam. When interacting with the specimen, the electron
beam loses energy in form of secondary electrons, backscattered electrons, characteristic
x-rays, and heat or photons, which provide signals of the surface properties of the
specimen. SEM can provide very high resolution images that show details ~1 nm, but the
resolution of SEM images is still generally at least an order of magnitude poorer than
those from transmitted electron microscope (TEM)21. However, due to the contrast of
secondary and backscattered electron signals and the large depth of field, SEM permits
the observation of the 3D shape of samples, while TEM can only obtain 2D images22.
Thus, SEM is a great tool to observe surface morphology of small structures.
The major limitation of applying the electron microscopy in molecular biology is
that most organic materials are not solid and electrically conductive. To solve this
problem, the biological samples are usually first dried on the spaceman holder and then
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coated with an ultrathin layer of electrically conducting material, such as gold or
platinum. Although material is coated with thin layer of metal, there are still chances for
the soft biological sample to be burned by the high energy electron beam. SEM, uses
lower energy electron beams, is more suitable for small oligomers and amorphous
aggregates. To keep experiment consistency, all the aggregate structures in the following
chapters were observed using SEM.
In chapters 3, 4, and 5, samples of amyloid fibrils and amorphous aggregates were
analyzed on a Hitachi S-4700 FESEM, a cold field emission high resolution scanning
electron microscope. Incubated samples were aliquoted in a Millipore Amicon® Ultra
centrifugal filters (3 kDa cut off) and the samples were diluted with MilliQ water. The
diluted samples were centrifuged and concentrated at 7,000 × g at 4 oC (3 repeats after
dilution with MilliQ water) to wash off salts and buffer. The washed samples were
aliquoted on scanning electron microscope (SEM) stubs and allowed to dry at room
temperature. The samples were coated with 10 nm platinum using a sputter coater.
Acceleration voltage of 10 kV and emission current of 5 μA were used to image the
samples.

2.5 Cell viability (MTS) assay
Cell viability assays are often performed in laboratories to determine if a test
molecule affects cell proliferation or shows direct cytotoxicity. Most cell-based assays
measure the toxicity by quantifying the number of viable cells at the end of the
experiment. The MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium)23 assay is a colorimetric method based on the tetrazolium
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reduction to measure redox metabolism of viable cells. The tetrazolium reagent MTS is
used in combination with an intermediate electron acceptor, phenazine methyl sulfate
(PMS), which can enter viable cells and become reduced in the cytoplasm or at the cell
surface by intracellular reductants, mostly NADH24. Once it exits the cells, PMS transfers
the electrons to MTS, converting this yellow color tetrazolium to a purple color formazan
product (Figure 2.7)24. The formazan production could be quantified by absorbance at
490 nm, which is proportional to the number of viable cells. While dead cells does not
have the ability to reduce tetrazolium into formazan. This difference permits
quantification of viable cells after incubation with substrates.

Figure 2.8. The intermediate electron acceptor PMS transfers an electron from
NADH in the cytoplasm to reduce MTS into MTS formazan.
In the following chapters, MTS assay was performed to measure the cytotoxicity of
protein amyloid fibrils, amorphous aggregates, and some intracellular fluorescent probes.
Human breast cancer cells MDA-MB-231 and SH-SY5Y human neuroblastoma cells
(from ATCC) were cultured in DMEM/F-12 medium with 10% FBS and 100 U/ml
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penicillin-streptomycin at 37 oC in 5% CO2 humidified environment and used for MTS
assays within the first 10 passages. The MDA-MB-231 cells were plated at 1 x 104
cells/well and SH-SY5Y cells were plated at 2 x 104 cells/well on 96-well plates and
allowed to grow overnight. The next day, the culture media were removed and cells were
washed with 1X PBS buffer (pH 7.4) twice. Then 100 μl fresh media containing test
samples at indicated concentrations were added to each well, and 6 replicates were
prepared for each sample. The cells were incubated with the samples for 48 h. Media
without any peptide were used as controls. To measure cell viability, 20 μl of CellTiter
96® AQueous One Solution Cell Proliferation (MTS) Assay kit (Promega) were added to
each well and incubated with cells at 37 oC for 4 h. Then absorbance at 490 nm were
collected using an ELISA plate reader (BioTek Instruments, Inc.). Blanks that contains
media and protein samples but no cells were similarly prepared and used for background
subtraction.

2.6 Live cell fluorescence imaging
Recently live cell fluorescence microscopy is used to observe biological molecules,
organelles, and many dynamic events in cells and tissues. The normal optical or electron
microscopy cannot efficiently distinguish different cellular organelles, while fluorescence
microscopy, can identify proteins and organelles are labeled with fluorescent probes
(Figure 2.9). Fluorescent probes can also be used to identify cellular changes in pH, or its
redox level. However, toxicity and photodamage effects from the chemical fluorescent
probes limit the observation of cell dynamics over extended periods of time.
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50 μm
Figure 2.9. Fluorescence microscope image shows a human normal endothelial cell.
The nuclei is stained in blue. The mitochondria and lysosomes are stained in green and
red, respectively. Image is adapted from Zhang et al.25 with permission from The Royal
Society of Chemistry.
In chapter 6, two live cell fluorescent probes for sensitive detection of lysosomal and
intracellular pH are tested on different mammalian cell lines. Breast cancer cells MDAMB-231 and normal endothelial cells HUVEC-C (from ATCC) were cultured in
DMEM/F-12 medium (MDA-MB-231) and Medium 199 (HUVEC-C) with 10% FBS
and 100 U/ml penicillin-streptomycin at 37 oC in 5% CO2 humidified environment and
used for experiment within the first 10 passages. Cells were plated on 12-well culture
plates at 1 x 105 cells/well and incubated at 37 oC in 5% CO2 incubator overnight. The
next day, the media was removed and cells were rinsed twice with 1 X PBS after which
fresh serum-free media was added and cells were incubated for 2 h at 37 oC in CO2
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incubator. Following 2 h serum starvation, fresh serum free media with/without
fluorescent probes (at indicated concentration) were added and incubated further with
cells for 2 h. Live cell images were acquired using an inverted fluorescence microscope
(AMF-4306, EVOSfl, AMG) with DAPI filter for Hoechst 33342 (Sigma-Aldich), GFP
filter for LysoSensor Green DND-189 (Invitrogen), and RFP or CY5 filters for test
fluorescent probes. The fluorescence images were obtained at 40x and 60x magnification
for HUVEC-C and at 60x magnification for MDA-MB-231 cells. The exposure times for
each filter were kept constant. Co-localization analysis based on Pearson’s coefficient
was done using JACoP plugin from ImageJ26.
To alter the intracellular pH during live cell imaging, normal endothelial cells
HUVEC-C (from ATCC) were cultured as previously described. After overnight
incubation in 12-well culture plates, cells were rinsed twice with 1 X PBS (pH 7.4). The
fresh serum free media with the test fluorescent probes were added to the cells and
incubated for 2 h. After incubation, the media were removed and cells were gently rinsed
with 1 X PBS (pH 7.4) three times. Cells were then treated with nigericin (5 μg/mL) in 2
mL potassium rich PBS (at pH 5.0, 5.5, 6.5, 7.5, and 8.5) and incubated for 15 min. Live
cell images were acquired using an inverted fluorescence microscope (AMF-4306,
EVOSfl, AMG) with DAPI filter for Hoechst 33342 (Sigma-Aldich), GFP filter for
LysoSensor Green DND-189 (Invitrogen), and CY5 filter for test probes. The
fluorescence images were obtained at 40x magnification. The exposure times for each
filter were kept constant.
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3.1 Introduction
Most proteins are functional in a narrow range of conditions where they are stable
and which can be altered by changes in pH, temperature, and/or ionic strength. Once
destabilized, proteins can misfold and aggregate resulting in loss of function or a novel
gain of toxic function that can lead to cellular or neuronal toxicity1-5. While, several
studies have reported on the formation of amorphous or β-sheet rich amyloid-like fibrils
due to denaturants and extreme pH, temperature, and/or ionic strength6-10, only a few
studies have been carried out at or near physiological pH11-14. It has been suggested that
most proteins can form β-sheet rich fibrils under properly designed laboratory conditions
that impact inter- and intra-molecular weak forces1, 2. Interestingly, in most of the
reported studies, proteins that form amyloid fibrils have intact disulfide bonds3, 4, 7, 15.
Disulfide bonds are critical to stabilizing protein structure and can either promote or
inhibit molecular interactions affecting fibrillation12,

16-18

; leaving the relationship

between disulfide bonds and protein aggregation still unclear19. Furthermore, previously
reported studies on disulfide-reduced proteins were performed at extreme pH or
temperature16, 17, 20, 21 in order to trigger aggregation/fibrillation. In addition, mutated or
fully denatured proteins lacking disulfide bonds were found to form amyloid fibrils9, but
these proteins are rare under physiological conditions. The cytosolic environment is
highly reducing and under certain conditions may have reduced glutathione levels as high
as 10 mM22. The cytosolic reducing agents like glutathione can break the disulfide
bonds23 resulting in protein misfolding leading to intracellular protein aggregates or
inclusions formation. On the other hand, reducing stress could also be created in
extracellular environment due to excessive or improper use of antioxidants24-26.
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In this study, we used dithiothreitol (DTT), a well-known thiol-based protein
disulfide reducing agent, to investigate disulfide-bond cleavage and protein aggregation
in two model proteins, hen egg white lysozyme (lysozyme) and bovine serum albumin
(BSA) at pH 7.2 and 37 °C21, 27-29. We also used a non-thiol based reducing agent, tris(2carboxyethyl)phosphine (TCEP), at pH 7.2 and 37°C to verify the findings from DTT
experiments. We chose lysozyme and BSA as both are globular, α-helical rich proteins
containing multiple disulfide linkages30, 31. Lysozyme is a small protein (129 amino acid
residues; 14.3 kDa) containing 4 disulfide bridges (C6-C127, C30-C115, C64-C80, and
C76-C94) and has mostly α-helices, a β-sheet, and a long loop (Figure 3.1). The bond C6C127 connects N- and C-terminals of the protein, and is partially exposed to solvent; the
other three disulfide-bonds are buried and are not solvent accessible32. Lysozyme under
disulfide-reducing conditions unfolds, loses its globular structure, and becomes a random
coiled polypeptide9,

33

. Fibrillar, amyloid-like structures have been reported

predominantly at non-physiological pH or in presence of denaturant such as guanidine
hydrochloride6, 9, 14, 34. Two other studies show that at high temperature and neutral/nearneutral pH, lysozyme can unfold and aggregate through hydrophobic interactions forming
particulates or non-fibrillar large aggregates35, 36. Earlier studies on lysozyme showed that
at acidic pH and high temperature the aggregation of protein resulted in fibril formation
and was dependent on disulfide-bond integrity. Fully reduced or oxidized lysozyme
formed fibrils6,

9

but the partially reduced lysozyme (50% of free –SH) did not form

amyloid fibrils even after 10 days of incubation21. These findings are very interesting but
require further study to understand the role of disulfide bonds in lysozyme aggregation.
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BSA is a large protein (583 amino acid residues; ~66 kDa) containing 17 disulfide
bridges and one free cysteine and is pre-dominantly α-helical with three homologous
domains (I, II, and III) that provide a variety of binding sites on the protein (Figure 3.1)31.
BSA shares 76% sequence homology with human serum albumin (HSA)8,

31

. Serum

albumin is an abundant transport protein that binds to acidic or lipophilic ligands, such as
fatty acids, bilirubin, hemin, and thyroxine, and transports it across the circulatory
system37. At pH that is between acidic to neutral (pH 5 to 7), almost all the disulfide
bonds are protected on BSA. However, when pH is increased from neutral to basic (pH 7
to 10), approximately 5 disulfide bonds out of 17 become solvent accessible and can be
cleaved by a reducing agent38, 39. In addition, raising the temperature from 35 oC to 55 oC
also increases the number of solvent accessible disulfide bonds on BSA40. Fully disulfide
reduced BSA protein was found to lose its native structure and binding abilities41.
Although, BSA is not related to any amyloidogenic disease, it is able to form aggregates
that are either amorphous in nature or show amyloid fibrillar structures under certain
laboratory conditions8, 13, 42, 43.
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Figure 3.1. Structures of lysozyme (A) and BSA (B), showing the disulfide bonds
(S-S, sand-yellow). The tryptophan residues are shown as purple-blue spheres. The
backbone is shown in grey color. The structures were generated using PyMOL 1.3 and
PDB files (1UCO)30 for lysozyme and (4F5S)31 for BSA.
Comparing and contrasting aggregation of lysozyme with BSA under identical
disulfide-reducing conditions can provide insights into how disulfide bonds affect protein
aggregation. Under the experimental conditions, both lysozyme and BSA formed
amorphous aggregates that are significantly different from the amyloid fibrils reported in
earlier studies. Interestingly, both lysozyme and BSA form amorphous aggregates that
show different properties; lysozyme forms highly flexible aggregates whereas BSA
aggregates are rigid and compact.

3.2 Materials and methods
Unless otherwise indicated, all materials were used as supplied by the manufacturer
without any further purification. Tris(2-carboxyethyl)phosphine (TCEP) was from
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Thermo Scientific Pierce; Lysozyme, BSA, DTT, Thioflavin T (ThT), 8-anilino-1naphthalenesulfonic acid (ANS) dye, 4,4’-Dianilino-1,1’-binaphthyl-5,5’-disulfonic acid
(bis-ANS) dye were purchased from Sigma.
Preparation of protein samples- Stocks of lysozyme and BSA were prepared by
dissolving lyophilized protein powder in 20 mM pH 7.2 sodium phosphate buffer having
150 mM NaCl. The protein samples reduced with TCEP were prepared in 20 mM pH 7.2
HEPES buffer having 150 mM NaCl instead of phosphate buffer. NaOH was added to 20
and 40 mM TCEP samples to neutralize the acidic TCEP HCl and maintain the final pH
at 7.2. The protein concentrations were determined by UV-visible spectroscopy using
extinction coefficient ε

280nm =

38,940 M-1cm-1 and ε280nm = 43,824 M-1cm-1 for lysozyme

and BSA, respectively. The working protein solutions (protein samples) had 40 μM
protein in 20 mM pH 7.2 phosphates buffer having 150 mM NaCl and 0 or 10 mM DTT.
All samples were prepared on ice and then incubated at 37 oC for the indicated time
periods (see figures for details). Lysozyme fibrils were prepared using the method from
Krebs et al. 20006. Briefly, 1 mM of lysozyme at pH 2.0 (in 20 mM glycine-HCl buffer)
was incubated at 65 oC for 7 days to generate the fibrils.
Seeding activity of disulfide-reduced protein aggregates- After 72 h incubation of
both lysozyme and BSA proteins with 10 mM DTT in 20 mM phosphate buffer (pH 7.2),
aggregates of both proteins were washed with water and then added to 40 μM of
respective protein solutions at physiological pH (20 mM phosphate buffer, pH 7.2,
having 150 mM NaCl) and acidic pH (20 mM glycine-HCl buffer, pH 2.0, having 150
mM NaCl). Aggregated protein seeds were added at a final concentration of 5%, 15%,
and 50% v/v concentrations, respectively. Negative controls were prepared under
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identical conditions but without adding seeds. All samples were prepared on ice and then
incubated at 37 oC for the indicated time periods (see Figure 3.7 for details).
Non-reducing gel electrophoresis- Non-reducing SDS-PAGEs were performed as
previous introduced in chapter 2. In brief, protein samples were first reacted with 5 mM
iodoacetamide, and then boiled with sodium dodecyl sulfate (SDS) sample buffer
(lacking reducing agent) for 3 minute. Fully reduced samples were freshly prepared and
boiled with SDS sample buffer containing 10, 40, or 100 mM DTT or 5% 2mercaptoethanol for 3 minute. Lysozyme (10 μg/lane) and BSA (5 μg/lane) samples were
loaded on 15% and 10% Criterion Tris-HCl polyacrylamide precast gels (Bio-Rad),
respectively. Tris-glycine-SDS buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3;
Bio-Rad) was used as running buffer and proteins were separated by sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE). The gels were stained with
Coomassie blue stain and image was acquired using a scanner.
UV-visible absorbance spectroscopy- All absorbance measurements were carried out
on Perkin Elmer Lambda 35 UV/VIS spectrometer as previous described in chapter 2. In
brief, protein samples were centrifuged at 20,000 × g for 5 minute after incubation. The
supernatant was collected and diluted to 50% with 20 mM pH 7.2 sodium phosphate
buffer and then absorbance was measured from 240 to 600 nm. All measurements were
done in triplicates. Controls were similarly prepared and incubated as the samples, had all
the ingredients as in the sample except protein, and were used for background subtraction.
Intrinsic and extrinsic fluorescence- Fluorescence measurements were performed on
Horiba Jobin Yvon spectrofluorometer (Fluoromax-4) at room temperature as previously
described in chapter 2. The samples were diluted with phosphate buffer (20 mM, pH 7.2;
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for DTT treated samples) or with HEPES buffer (20 mM, pH 7.2; for TCEP treated
samples) to a final protein concentration of 10 or 5 μM for fluorescence experiments.
Intrinsic fluorescence spectra for lysozyme and BSA (5 μM) were collected in 300-450
nm range with excitation at 280 nm. Extrinsic fluorescent dyes were dissolved in ethanol
and then freshly diluted with phosphate buffer (or HEPES buffer for TCEP treated
samples) as working stocks at concentration of 350 μM (ANS), 70 μM (bis-ANS), and
700 μM (ThT) for incubation with the protein samples. ANS and bis-ANS were used at a
final concentration of 5 μM and 1 μM, respectively, with 15 minute equilibration with 10
μM of proteins in samples on ice. Fluorescence spectra (400-700 nm range) were
collected with excitation at 380 nm for ANS and 360 nm for bis-ANS. For ThT
fluorescence, 10 μM dye was incubated with 5 μM proteins on ice for 30 minute and
emission spectra (460-700 nm range) was collected with excitation at 450 nm. All
samples containing fluorescent dyes were incubated in dark for the time indicated before
the emission spectra were acquired. All measurements were done in triplicates.
Bandwidths for excitation and emission were set at 2 nm. Controls were similarly
prepared and incubated as the samples, had all the ingredients as in the sample except
protein, and were used for background subtraction.
Field Emission Scanning Electron Microscopy (FESEM)- FESEM images were
acquired on a Hitachi S-4700 FESEM microscope as previously described in chapter 2. In
brief, samples were washed using a Millipore Amicon® Ultra centrifugal filters (3 kDa
cut off) with double-distilled water to remove salts and buffer. The washed samples were
aliquoted on scanning electron microscope (SEM) stubs and allowed to dry at room
temperature. The samples were coated with 10 nm platinum using a sputter coater.
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Acceleration voltage of 10 kV and emission current of 5 μA were used to image the
samples.

3.3 Results
In this study, lysozyme and BSA proteins were incubated with 0-100 mM of DTT at
pH 7.2 and 37 °C for the indicated time periods and aggregation was monitored by
different techniques. Changing the concentration of DTT altered the aggregation kinetics
slightly but did not affect the nature of aggregates observed (Figure 3.2). Therefore, we
chose 10 mM DTT for all our subsequent studies with proteins as it showed optimum
response. We incubated the proteins in the presence or absence of 10 mM DTT at pH 7.2
and 37 °C for the indicated time periods and aggregation was monitored by different
techniques. The protein samples were centrifuged and the concentration of protein in the
supernatant (soluble fraction) was measured by UV-visible spectroscopy and morphology
of aggregates was characterized by scanning electron microscope (Figure 3.3). The
amount of soluble protein did not change over time in the protein samples incubated in
the absence of DTT (Figure 3.3A, B, open symbols). In addition, no aggregates were
observed in the SEM images (Figure 3.3C, H). However, for protein samples incubated in
the presence of 10 mM DTT, the fraction of soluble protein decreased significantly in 4 h
(Figure 3.3A, B, closed symbols). After 12 h, < 20% of soluble proteins were detected in
the sample solution (Figure 3.3A, B). Insoluble protein aggregates, as visualized by SEM,
increased in amount and size as the incubation time increased for samples in the presence
of 10 mM DTT (Figure 2E-F, I-J). For both proteins, the aggregates were amorphous
with an average subunit diameter of 400 ± 200 nm. Even when the DTT-treated lysozyme
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was incubated for a longer time (48-day sample, Figure S6), the aggregates were still
amorphous in nature.

Figure 3.2. The effect of increasing concentrations of DTT on lysozyme and BSA
aggregation are monitored by intrinsic fluorescence (A, C) and ThT assay (B, D) and
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SEM (E-L). Intrinsic and ThT fluorescence results showed the protein aggregation of
lysozyme (A, B) and BSA (C, D) in 0-24 h. Error bars indicate ± S.D. Aggregates formed
in presence of 5 mM (E, I), 10 mM (F, J), 40 mM (G, K), and 100 mM (H,L) DTT from
lysozyme (E-H) and BSA (I-L) were images using SEM. Scale bars = 1 µm.

Figure 3.3. UV absorbance showing the fraction soluble protein and SEM images of
the insoluble aggregates. Protein samples were incubated at 37 °C for the indicated
periods of time and then centrifuged. Fraction soluble proteins in supernatant were
determined by UV absorbance at 280 nm for lysozyme (A) and BSA (B). Error bars
indicate ± S.D. Insoluble aggregates were imaged using SEM. The samples for lysozyme
and BSA respectively are: proteins incubated without DTT (C, G; scale bars = 10 µm);
with 10 mM DTT for 0 h (D, H; scale bars = 10 µm), 4 h (E, I; scale bars are 50, 5, and 1
µm from left to right), and 7 days (168 h) (F, J; scale bars are 50, 5, and 1 µm from left to
right).
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Non-reducing gel electrophoresis was used to check if proteins under the
experimental conditions were fully disulfide reduced or formed higher molecular weight
protein species as the incubation time increased (Figure 3.4). For samples incubated in
the absence of DTT, no new high molecular weight protein species were observed even
after 48 h and was comparable to freshly prepared fully oxidized protein samples (Figure
3.4; lane O in panels A, B, and C). Freshly prepared proteins that were fully reduced by
2-mercaptoethanol (Figure 3.4; lane R in panels A, B and C) showed a slight decrease in
electrophoretic mobility compared to the fully oxidized protein samples (Figure 3.4; lane
O in panels A, B and C) but did not show any additional higher molecular weight protein
bands. While 10 mM DTT in sample buffer is not sufficient to completely reduce BSA,
40 mM and 100 mM DTT resulted in complete reduction of BSA (Figure 3.4; compare
lanes R and R’). However, for samples incubated in the presence of 10 mM DTT,
appearance of higher molecular weight protein species were observed for lysozyme as
early as 4 h (Figure 3A). Higher molecular weight protein bands increased with
increasing incubation time. In the case of BSA, the major protein band is at ~66 kDa that
faded with time and a smear of protein in the higher molecular weight region was
observed for protein incubated for 24 h or more (Figure 3.4B, C). The DTT-treated BSA
proteins incubated for 2 h or longer also showed a mixture of reduced (R) and oxidized
(O) proteins (Figure 3.4B). Even BSA proteins treated with high concentrations of DTT
(40 or 100 mM DTT) showed mixture of reduced (R) and oxidized (O) proteins at 48 h
(Figure 3.4C). To check if the high molecular weight protein species are present in
soluble fraction or not, samples from different timed incubation (1, 2, 4, 24, 48, and 72 h)
were centrifuged at high speed and pellets and supernatant were analyzed by non79

reducing SDS-PAGE (Figure 3.4D). All high molecular weight protein species were
observed in the pellet fraction only.

Figure 3.4. Non-reducing SDS-PAGE indicated the presence of high molecular
weight species. Lysozyme (10 μg/lane) and BSA samples (5 μg/lane) were loaded on
15% gel (A) and 10% gel (B, C), respectively. The gels were run at 80 V for 3.5 and 4
h (lysozyme and BSA, respectively) followed by staining with Coomassie blue. Lanes
“O” were fully oxidized proteins that reacted with iodoacetamide in the absence of
DTT. Lanes “R” in panel A, B, and C were proteins that were fully reduced by 2mercaptoethanol. Loading orders are same for gels A and B. Lanes “R’” in panel C
were BSA samples boiled in sample buffer containing 10, 40 or 100 mM DTT instead
of 5% 2-mercaptoethanol. The last two lanes on panel C were BSA samples treated
with 40 and 100 mM DTT for 48 h. In panel D lanes “S” and “P” were soluble fractions
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and insoluble pellets in samples, respectively.

* signifies the presence of high

molecular weight protein species.
Conformational changes, hydrophobic exposure, and aggregation in lysozyme and
BSA were monitored by intrinsic fluorescence and by extrinsic fluorophores such as 8anilino-1-naphthalene sulfonate (ANS), 4,4'-dianilino-1,1'-binaphthyl-5,5'-disulfonic acid
(bis-ANS), and Thioflavin T (ThT). Intrinsic fluorescence intensity for disulfide-reduced
lysozyme increased rapidly in the first 4 h followed by a fast and significant decrease in
fluorescence up to 72 h (Figure 3.5A). After 72 h the decrease in fluorescence intensity
was slow. On the other hand, the intrinsic fluorescence for disulfide reduced-BSA
showed a very rapid drop in fluorescence up to 24 h (Figure 3.5B). After 24 h, the
decrease in fluorescence slowed down considerably. Both lysozyme and BSA that had
intact disulfide bands (samples with no DTT) showed negligible fluorescence changes
over time (Figure 4).
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Figure 3.5. Intrinsic fluorescence peak intensities over time for both lysozyme and
BSA proteins. Fluorescence spectra for 5 μM each of lysozyme and BSA were collected
from 300-450 nm with excitation at 280 nm. Peak emission wavelength of 346 nm and
336 nm were selected for lysozyme (A) and BSA (B), respectively. Peak fluorescence
intensities are shown using open symbols (without DTT) and closed symbols (with 10
mM DTT) as a function of time. Inset shows a plot for the first 4 h of incubation. Error
bars indicate ± S.D.
The disulfide-reduced lysozyme and BSA showed opposite trends for ANS and bisANS fluorescence (Figure 3.6). In the case of DTT-treated lysozyme samples, ANS
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(Figure 3.6A) and bis-ANS (Figure 3.6C) probes showed increased fluorescence with
fluorescence increasing rapidly for the first 4 h (Figure 3.6A, C). After 4 h, the
fluorescence plateaued and no significant change in fluorescence was observed as a
function of time (Figure 3.6A, C). However, DTT-treated BSA showed a rapid decrease
in ANS fluorescence for the first 4 h followed by a slower decrease in fluorescence over
time (Figure 3.6B). Interestingly, bis-ANS showed a similar decrease in fluorescence for
BSA proteins treated with or without DTT (Figure 3.6D). The aggregation of proteins
monitored by ThT showed increased fluorescence intensity for DTT-treated lysozyme
and BSA in the first 4 h (Figure 3.7A, B; closed symbols) whereas, protein samples in the
absence of DTT showed no change in ThT fluorescence (Figure 3.7A, B; open symbols).
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Figure 3.6. Changes in protein hydrophobicity and aggregation were monitored by
ANS and bis-ANS fluorescence. 10 μM of protein samples were incubated with 5 μM
ANS or 1 μM bis-ANS for 15 minute, before acquiring spectra. Emission spectra for
lysozyme (A, C) and BSA (B, D) were collected from 400-700 nm with excitation at 380
nm for ANS and 360 nm for bis-ANS. Average emission peak wavelength of 471 nm and
484 nm were selected for ANS (A, B) and bis-ANS (C, D), respectively. Peak
fluorescence intensities are shown using open symbols (without DTT) and closed
symbols (with 10 mM DTT). Inset shows plot for first 4 h of incubation. Error bars
indicate ± S.D.

Figure 3.7. ThT fluorescence of protein aggregates and lysozyme fibrils. Emission
spectra for 5 μM of lysozyme and BSA in presence of 10 μM ThT were acquired from
460-700 nm with excitation at 450 nm. Average emission peak wavelength of 486 nm
and 484 nm were selected for lysozyme (A) and BSA (B), respectively. Peak
fluorescence intensities are shown as open symbols (without DTT) and closed symbols
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(with 10 mM DTT). Inset shows a plot for first 4 h of incubation. Error bars indicate ±
S.D. Fluorescence spectrum showing signal for 5 μM lysozyme fibril and amorphous
aggregates from 7-day old samples incubated with 10 μM of ThT dye (C). SEM images
shows structures of lysozyme fibril (D) and lysozyme aggregates (E) from 7 day old
samples (scale bars = 5 µm).
SEM analysis (Figure 2) of disulfide reduced lysozyme and BSA proteins showed
that aggregates are amorphous in nature that stays amorphous even upon longer
incubation. To further investigate if formation of these aggregates are seed-dependent or
whether seeding can lead to fibril formation or not, we carried out cross-seeding assays at
two different pHs (pH 7.2 and pH 2.0; Figure 3.8). The aggregates formed from 72 h
incubated disulfide-reduced proteins (lysozyme and BSA) were washed and added as
seeds (5%, 15%, and 50% v/v) into respective lysozyme and BSA protein solutions
having intact disulfide bonds (native proteins). Proteins even with small amount of seeds
(5% v/v aggregated proteins) initiated aggregation of native proteins at pH 7.2 that share
similar morphology with the seeds and showed increased binding to ThT (Figure 3.8, A,
B, E, G). In contrast, at pH 2.0, no increase of ThT fluorescence was observed except for
lysozyme and BSA that showed increase in ThT fluorescence with 50% seeds (Figure
3.8C, D). And after 72 h, no structured species could be found by SEM, indicating
aggregates were destabilized at acidic pH.
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Figure 3.8. Effect of seeding of lysozyme and BSA aggregates on native protein
monitored by ThT fluorescence. 5%, 15% and 50% (v/v) of aggregates generated by
incubating lysozyme and BSA protein at pH 7.2 and in presence of 10 mM DTT were
added as seeds to 40 µM native protein solutions and incubated at 37°C: lysozyme pH 7.2
(A, E), lysozyme pH 2.0 (C, F), BSA pH 7.2 (B, G), and BSA pH 2.0 (D, H). ThT
fluorescence experiments were performed as detailed in Figure 6. Error bars indicate ±
S.D. SEM images (E-H) show morphology of aggregates formed with 15% seeds after 72
h of incubation (scale bars = 10 µm).
To further confirm the role of disulfide bonds in aggregation, we incubated protein
samples with TCEP, a non-thiol based reducing agent, and monitored protein aggregation
by intrinsic and ThT fluorescence (Figure 3.9, A-D). As TCEP in not stable in phosphate
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buffer, especially around neutral pH, we changed buffer to HEPES (20 mM, pH 7.2).
Without adding TCEP, both proteins remained stable, and no aggregates was observed up
to 24 hours. The intrinsic fluorescence data for lysozyme samples showed an increase in
fluorescence in first 4 h a trend similar to DTT treated samples but upon longer
incubation remained steady instead of decreasing in intensity (Figure 3.5A, 3.9A).
However, intrinsic fluorescence for TCEP treated BSA, and ThT fluorescence for
lysozyme and BSA showed trends similar to that observed for DTT treated protein
samples (Figure 3.5B, 3.7A, 3.7B, 3.9B-D). SEM images showed amorphous aggregates
for proteins incubated with 2 mM TCEP (Figure 3.9 E, F) that share morphology similar
to aggregates seen for proteins incubated with 10 mM DTT (Figure 3.3 E, F, I, J).
Interestingly, we did not observe aggregates of either lysozyme or BSA incubated with 5
mM or more TCEP in 24 h.
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Figure 3.9. Concentration dependence of TCEP on protein aggregation. Protein
aggregation rates were monitored using intrinsic fluorescence (A, B) and ThT
fluorescence (C, D) for lysozyme (A, C) and BSA (B, D). Error bars indicate ± S.D.
Intrinsic fluorescence experiments were performed as detailed in Figure 4 and ThT
fluorescence experiments were performed as detailed in Figure 6. SEM images for
aggregates of lysozyme and BSA in presence of 2 mM TCEP are shown in panels (E) and
(F), respectively. Scale bars = 10 µm.
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3.4 Discussion
Disulfide bonds are formed naturally in 65% of secreted proteins, 15% of human
proteome, and in more than 50% of amyloidogenic proteins19. The native disulfide bonds
are critical for correct folding and normal function of proteins, and the disruption of
disulfide bonds were shown to alter protein structures and even result in protein
aggregation9, 23, 44. Although cellular redox status can be tuned by certain reducing agents
26

, cells have great coping mechanism to resist changes. In this study we chose DTT, a

disulfide reducing agent to mimic the excessive or improper use of thiol-based
antioxidants at physiological pH and temperature. The role of disulfide bonds have been
previously studied using strong reducing agents45, single site mutations 9, artificial
disulfide linkages

18

, and/or at extreme pH conditions16. Therefore, we wanted to study

how disulfide-reduced proteins misfold and form aggregates at physiological pH in
absence of any other destabilizing influences. The two proteins (lysozyme and BSA) used
in this study could form amorphous aggregates but with unique structural properties.
UV absorbance and fluorescence spectroscopy data showed that both lysozyme and
BSA protein samples that lack DTT were stable at 37 °C up to 4 weeks with no
measurable changes in their spectral properties (Figure 3.3 and Figures 3.5-3.7). In
addition, no visible aggregates were observed for the proteins by SEM (Figure 3.3C, G).
This suggests that these two proteins are stable at pH 7.2 and 37 °C for long term in the
absence of any destabilizing influence. But for proteins incubated at 37 °C in the
presence of reducing agent (10 mM DTT), we observed amorphous aggregates appearing
as early as 2 h, signifying the importance of disulfide-bond integrity in providing protein
stability (Figure 3.3E). This is in contrast to the fibrils found in several previous studies
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performed at extremes of pH or temperature in combination with other solvent additives9,
20, 23, 34

. The amorphous aggregates in this study are ~400 nm in diameter with a

maximum length of 30 μm (Figure 3.3) that shares some physicochemical characteristics
with protofibril, such as size (lysozyme aggregates) and ThT binding capacity. An earlier
study shows that ThT positive amorphous aggregates were able to convert into
protofibrils after long term incubation, and eventually formed long, unbranched fibril
structure46. However, under our experimental conditions, the DTT-treated aggregates
were not able to convert into fibrils with increased incubation time (Figure 3.10).
Although DTT-treated lysozyme and BSA aggregates show rapid increase in ThT
fluorescence (Figure 3.7A,B), the ThT signal from aggregates is low and about 1/5th
compared to a mature fibril under identical experimental conditions (Figure 3.7C). ThT is
a well-known dye for characterizing amyloid-like structures47; however, recent studies
have shown that some non-fibril/amorphous aggregates were able to bind ThT and show
ThT characteristic fluorescence at ~485 nm48. The different fluorescence intensities of
mature fibril and the aggregates could be caused by difference binding modes of ThT on
these structures. It is widely studied and believed that ThT binds to the grooves parallel to
the long axis of amyloid fibrils and is stabilized by the hydrophobic and aromatic amino
acid side chains 49. The DTT treated aggregates have very distinct structure from amyloid
fibrils (Figure 3.7D, E) but ANS fluorescence results (Figure 3.6A, B) shows the
aggregates are very hydrophobic, indicating the ThT molecules could bind to the
hydrophobic pockets on the aggregates49. In other cases, Groenning and colleagues50
showed that β-sheet rich proteins, β-cyclodextrin and transthyretin, could tightly bind
ThT molecule without inducing the characteristic fluorescence as the binding site on
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proteins was smaller than 8 Å. However, non-β-sheet proteins, γ-cyclodextrin and
acetylcholinesterase could induce high ThT fluorescence signal similar to amyloid fibrils
as these two proteins had structures with cavity diameters of 8-9 Å, allowing binding of
ThT molecules50. This is in line with another study showing ThT fluorescence can be
induced by non-fibril, protofibril-like aggregates48. Another key factor of ThT
fluorescence is the rotation of the single bond connecting the benzothiazole ring and the
dimethylaminobenzene ring. Wolfe et al.51 compared the co-crystal structures of ThT
with monomeric and amyloid-like oligomer of β-2 microglobulin (β2m) and found that
the twisted angle φ of the ThT single bond is ~60o in present of amyloid-like oligomers
while φ = ~30o when ThT binds to β2m monomers. Therefore, the weak ThT
fluorescence of DTT treated aggregates could be result of the binding mode of ThT, or
the twisted angle φ. However, before taking enough atomic level information about the
binding of ThT with amorphous aggregate, we are not able to make any clear conclusion
of the mechanism of modest ThT fluorescence of DTT treated aggregates. Even though
the lysozyme aggregates in this study are more “structured”, there is no direct evidence
demonstrating that these aggregates could be classified as protofibrils or protofibril-like
aggregates.
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Figure 3.10. Lysozyme and BSA samples which were incubated for long time at
37 °C show amorphous aggregates only. Lysozyme (A, B) and BSA (C) aggregates were
imaged after 14 days (A, C) and 48 days (B) of incubation at 37 oC in presence of 10 mM
DTT. Scale bars are 50, 5, and 1 μm from left to right in each panel.
Non-reducing SDS-PAGE was used to visualize higher molecular weight crosslinked protein species that can arise due to the scrambling of disulfide bonds (Figure 3.4).
The non-reducing gel electrophoresis for lysozyme shows appearance of distinct high
molecular weight bands as early as 4 h that can result from disulfide-bond scrambling
(Figure 3.4A). This is in line with an earlier study that reported formation of scrambled
disulfide-bonds for lysozyme in the presence of 2-mercaptoethanol, a disulfide reducing
agent18. Based on an earlier study the 17 disulfide-bonds in BSA can be grouped in three
classes centered on their location and susceptibility to disulfide reducing agent: fully
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exposed (reactive with 0.5 mM DTT), partially buried (reactive with 10 mM DTT), and
buried (nonreactive in native solution without any denaturants)52. For a full reduction of
disulfide bonds of the BSA polypeptide chain, 110-218-fold molar excess of DTT is
required28. In this study, the use of 10 mM DTT is only a 14-fold molar excess for BSA
disulfide bonds. Therefore, we do not expect complete reduction of all the disulfide
bridges in the BSA polypeptide chain (Figure 3.4C; see lane R’). Partial disulfide
reduction can promote scrambling of disulfide bonds resulting in higher molecular weight
species (Figure 3.4B). “R” and “O” bands indicate the presence of a mixture of reduced
(R) and oxidized (O) proteins in the DTT-treated BSA samples after 4 h of incubation
(Figure 3.4B). Presence of high molecular weight protein species in BSA samples treated
with 40 mM or 100 mM DTT at 48 h suggests that proteins are not fully reduced even at
high concentrations of DTT under the incubation conditions (Figure 3.4C). The atypical
electrophoretic mobility of DTT-treated BSA samples is due to mixture of partially
oxidized and reduced proteins affecting the overall hydrodynamic volume of proteins
(apparent size) and hence its migration on SDS-PAGE53, 54. In the gel “R” and “O” bands
started to be clearly visible from 2 h and their intensities did not change after 4 h which is
in line with trend of fluorescence results (Figure 3.5B, 3.6B, and 3.7B). This suggests that
presence of scrambled (inter-/intra-molecular) disulfide bonds may be critical in driving
and further stabilizing the amorphous aggregate formation (Figure 3.3, 3.11).
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Figure 3.11. A generic aggregation model based on the results of both lysozyme and
BSA proteins treated with 10 mM DTT at pH 7.2 and 37 °C. Incomplete reduction of
disulfide-bonds in proteins can affect misfolding and can result in formation of scrambled
disulfide bonds (both inter- and intra-molecular) affecting the aggregation process. This
can favor formation of amorphous aggregates over amyloid like structure.
Intrinsic fluorescence can provide information on protein conformational changes by
measuring tryptophan fluorescence that is very sensitive to its local microenvironment.
Although both lysozyme and BSA showed similar aggregation kinetics with major
structural changes observed within first 4 h, they gave different fluorescence responses.
Lysozyme showed an increase in intrinsic fluorescence for first 4 h followed by a rapid
decrease in fluorescence signal (Figure 3.5A). The major contributors of intrinsic
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fluorescence in native lysozyme are Trp 62 and Trp 10855, which are exposed to the
solvent56. The other Trp residues are either tightly packed inside the structure (Trp 111
and Trp 123), or are located near disulfide bonds (Trp 28, Trp 63, Trp 111, Trp 123),
which have Cys-linked sulfurs that can act as fluorescence quenchers55. Therefore, the
increase of lysozyme intrinsic fluorescence in the first 4 hours could be a result of
disulfide bonds breaking with and exposing Trp residues decreasing the quenching
effects of reduced sulfur groups in the unfolded structure. Free thiols upon longer
incubation can form scrambled disulfide bonds and quench intrinsic fluorescence as the
aggregated proteins may have a more packed structure that may also bring the Trp
residues closer to Cys residues. DTT-treated BSA showed a very different fluorescence
response compared to that of lysozyme (Figure 3.5B). The major difference may be due
to the size of the protein (66 kDa), number of disulfide bonds (17 S-S bonds) per
molecule of protein, and location of aromatic residues in the protein structure31. BSA is a
big protein with only two tryptophan residues (W-134 and W-213), and neither of them is
located on the protein’s surface. A blue shift in the emission peak that is associated with a
decrease in fluorescence intensity is consistent with aggregation leading to shielding of
Trp residues and its fluorescence being quenched by close proximity of other groups such
as free Cys or peptide bond 57, 58 (Figure 3.12A).
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Figure 3.12. Intrinsic fluorescence peak intensity and wavelength shifts over time
for BSA protein. Peak fluorescence intensities are shown in black and wavelength for
peak maxima are plotted in red. The results from first 4 hour were zoomed as inset
figures. Error bars indicate ± S.D.
As all of the Trp residues in lysozyme and BSA are located near hydrophobic
clusters17,

31, 59

, we used hydrophobic probe ANS to detect change in protein

hydrophobicity. ANS is very sensitive to local solvent environments, shows high
fluorescence and is blue shifted when buried in hydrophobic pockets, or shows decreased
fluorescence that is red shifted when exposed to more polar environment47,

60, 61

. In

presence of ANS, lysozyme showed a rapid increase in fluorescence for the first 4 h with
subsequent fluorescence plateau (Figure 3.6A). This was mirrored by a shift in
wavelength for peak cps from ~510 nm (considerable exposure to polar solvent) to ~470
nm (indicative of buried in hydrophobic core) and was stable around 470 nm after that
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(Figure 3.12B). The high fluorescence signal and blue shift suggests that lysozyme
aggregates maybe flexible permitting tight binding of ANS molecules to the protein47, 62,
63

. To further study the flexibility of protein aggregates, we used the dimeric analog of

ANS, bis-ANS, that has larger ring structure and does not bind tightly to organized
structures, even if hydrophobic. Bis-ANS requires a flexible molten globule like
structures for tight binding64,

65

, and reacts weakly to amyloid fibrils66. Bis-ANS

fluorescence of lysozyme aggregates suggests DTT reduced lysozyme aggregates have a
highly flexible structure (Figure 3.6C). The continued high bis-ANS fluorescence of
reduced lysozyme after 4 h indicates that aggregates of lysozyme even after long-term
incubation were still flexible and had not converted into more organized and rigid
structures. As ANS and bis-ANS have net negative charge we investigated the effect of
ionic strength on fluorescence of lysozyme aggregates (Figure 3.13). Although it has
been reported that high ionic strength can affect lysozyme structure67, the removal of
NaCl in this study did not affect lysozyme aggregation, suggesting that electrostatic
interaction is not a major force driving the interaction at pH 7.2.
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Figure 3.13. Effect of ionic strength (NaCl) monitored by UV absorbance, intrinsic
and ThT fluorescence. Both lysozyme (A-C) and BSA (D-F) protein samples were
prepared in presence (closed symbols) or absence (open symbols) of 150 mM NaCl
having 0 (black) or 10 mM (red) DTT. Fraction soluble proteins at 280 nm (A, D) were
estimated by UV absorbance. The peak intensities of intrinsic fluorescence (B, E) at 346
nm (for lysozyme) and 336 nm (for BSA) were plotted. For ThT assay (C, F): protein
samples (5 μM) were incubated with 10 μM ThT, and peak fluorescence intensities at 486
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nm (for lysozyme) and 484 nm (for BSA) were plotted. The results from first 4 hour were
zoomed as inset figures. Error bars indicate ± S.D.
Different from lysozyme, the reduced BSA showed a dramatic decrease in ANS
fluorescence in first 4 h and then was stable at low signal level for long term (Figure
3.6B). The BSA samples with intact disulfide bonds (lacking DTT) showed high ANS
fluorescence (Figure 3.6B). This could be because ANS can bind to the hydrophobic
pockets on BSA and its fluorescence intensity and quantum yield depend upon the degree
of exposure to solvent61, 68. In addition, serum albumin is a transport protein with highly
flexible native structure and has many binding sites for lipids or drugs that can also bind
ANS37. The decrease in ANS fluorescence of DTT-treated BSA could be due to exposure
of hydrophobic regions to the solvent phase, or collapsing and aggregating of
hydrophobic regions that can be a result of scrambling of disulfide bonds, as BSA is only
partially reduced under the experimental conditions. Peak emission wavelength for
fluorescence in the 470 nm range suggests poor but hydrophobic binding of the dye, that
maybe a result of rigid amorphous structure (Figure 3.12B). Bis-ANS was used to further
investigate protein flexibility changes in oxidized and reduced BSA. Interestingly, we
found that both DTT-treated and DTT lacking BSA samples had weak interactions with
bis-ANS (Figure 3.6D). Bis-ANS was found to have dual effect on protein structure
through binding: high concentration of bis-ANS induces more disordered protein
structures, while at low concentration, binding with bis-ANS results in tighter
conformers65. Thus, in the case of the DTT lacking BSA samples, the equilibrium could
shift from native conformation to a tighter conformer after binding bis-ANS. Native BSA
has high affinity binding sites for ANS and bis-ANS, but on non-native conformations,
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only low affinity binding sites were found65. Plus the structure of DTT treated BSA
aggregates are relatively rigid (Figure 3.3 I, J), indicating weak binding with bis-ANS.
Therefore, we only observed weak bis-ANS fluorescence with both native and aggregated
BSA samples.
In the cross-seeding experiments, the amorphous aggregates were able to act as seed
and lead to rapid aggregation of native proteins at pH 7.2 (Figure 3.8), suggesting a low
energy barrier between the native conformation and the aggregates69, 70. In addition, the
association of native proteins to seeds could also be driven by hydrophobic interactions,
knowing that the aggregates have high ANS binding capacity (Figure 3.6). Whereas, the
cross-seeded proteins at pH 2.0 (Figure 3.8) did not induce aggregation of native proteins.
This may be due to difference in molecular organization of native proteins that favor
fibril formation at pH 2.048 . In addition, the scrambling of disulfide bonds increased the
tendency for molecular self-assembling and collisions that results in lack of large
homogeneous structures. Similar findings have been reported in previous studies of
amyloid-β peptide48 and β2-microglobulin71. Therefore, the amorphous aggregates of
disulfide-reduced proteins at pH 7.2 are probably formed through a kinetically trapped
pathway, due to strong inter-/intra-molecular association caused by disulfide scrambling.
To further confirm the formation of amorphous aggregates observed in this study is a
result of disulfide scrambling and not thiolated side product of DTT oxidation, we treated
the proteins with 0 to 40 mM TCEP (Figure 3.9). It’s noticeable that in presence of 2 mM
TCEP, both lysozyme and BSA, show strong measurable fluorescence signals. Knowing
that TCEP has stronger reducing activity72 and longer half-life than DTT73, high
concentration of TCEP could inhibit disulfide scrambling, which is the driving force for
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the formation of amorphous aggregates observed in this study. SEM images of protein
samples incubated with 2 mM TCEP formed amorphous aggregates (figure 3.9 E, F) that
share morphology very similar to 10 mM DTT treated protein samples. However, we did
not observe aggregates of either lysozyme or BSA up to 24 h with TCEP concentration
higher than 5 mM. The high concentration of TCEP could possibly inhibit the scrambling
of disulfide bonds and hence can affect the formation of amorphous aggregates. Since the
result with 10 mM DTT could be reproduced with low concentration of TCEP (2 mM),
we believe that the formation of amorphous aggregates in presence of 10 mM DTT is a
result of disulfide scrambling.

3.5 Conclusion
In summary, under the experimental conditions reported in this work, both disulfide
reduced lysozyme and BSA showed increased susceptibility to form amorphous
aggregates that have very distinct structures. Both proteins show increased ThT binding
but the fluorescence signal is still low compared to amyloid fibril. The lysozyme
aggregates show higher structural flexibility in comparison to BSA aggregates.
Formation of amorphous aggregates for these two proteins is a result of the interplay of
disulfide bond scrambling and hydrophobic interactions that could kinetically affect the
overall aggregation pathway (Figure 3.11).

Cross-seeding experiments into native

proteins for both proteins could only promote aggregation at pH 7.2 but not for proteins
at acidic pH. This may be due to surface charge differences on proteins resulting in
unique molecular organization at different pHs.
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4.1 Introduction
Protein

misfolding/aggregation

was

long

believed

to

hold

the

key

to

neurodegenerative diseases, among which Alzheimer’s disease (AD) is most known and
now affects 5.3 million Americans, with a total cost of $217.7 billion in 20141, 2. Without
preventative treatments or effective therapeutic methods, the number of people suffering
from AD in the US is expected to be 10 million by 20501, 2. The extracellular amyloid
plaques formed from amyloid β (Aβ) peptide was identified as one of the major
hallmarks of this disease3. Aβ peptides vary in length from 39 to 43 amino acids4. In a
normal human brain, about 76-90% of Aβ peptides are Aβ40, whereas only <10% are the
more aggregation-prone one, Aβ425-7. Since the discovery of Aβ 30 years ago, great
efforts have been done on understanding Aβ fibrils8 and the associated toxicities9, 10.
However, the toxic structure of Aβ is still not defined. Many drugs or therapies have been
developed in the past decades, but none to date shows clinical efficacy. In the past 5 years,
over 5,000 projects and $3 billion of funds contributing to researches of AD and related
dementias2. However, development of AD treatment is limited by the large variety of the
highly transient dynamics of Aβ species that is naturally formed in the brain8, 10.
The in vivo “pool” of Aβ contains not only the Aβ peptides in different length, but
also the post-translated modified forms10. It has been well established that the
posttranslational modifications (PTMs) play an important role in protein folding and
aggregation. Extracellular phosphorylation on Aβ accelerates the self-assembling of this
peptide into neurotoxic aggregate species11-13. Other modifications, such as
phosphorylation11-13, truncation14-16, isomerization17, 18, and pyroglutamate formation16, 19,
were also found to influence Aβ aggregation propensity and cytotoxicity. Glycosylation
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was detected on Aβ42 in human cerebrospinal fluid, but the functional effects are still not
clear20. Acetylation was recently found to be caused by the highly electrophilic diacetyl
radicals that are related to many diseases21-24. In the case of AD, acetylation on tau was
recently identified and was proposed as a new therapeutic target25,

26

. Interestingly,

acetylation on Aβ peptide was not as well studied as other modifications. Aβ acetylation
on residue K28 has been previously demonstrated on Aβ25-35 fragment, showing
negligible effect on the overall fibril morphology27, but little is known about the effect of
acetylation on full length Aβ42 peptide.
The Aβ42 peptide has two lysine residues, K16 and K28 (Figure 1A). K16
contributes to amyloid fibril formation by serving as part of an intermolecular binding
sequence (K16-F20)28. While K28 forms a salt bridge with A42 in Aβ42 fibrils (Figure
1B)29, or with D23 in Aβ40 fibrils30, to stabilize the β-sheet structures of amyloid fibrils.
Both lysine residues link to familial (K16N) and nonfamilial (K16A, K28A) mutations
that cause early onset dementia in Alzheimer’s disease31, 32. Replacing lysine with alanine
could affect the α-helical structure (K16A)33 or the intrapeptide hydrophobic interaction
(K28A)34. However, K16R and K28R mutations on Aβ40 peptide did not affect the
formation of amyloid fibrils35.
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Figure 4.1. Sequence Aβ1-42 (A) and atomic structure model of Aβ42 monomer (B,
in aqueous solution, PDB code: 1Z0Q36) and mature fibril (C, PDB code: 2MXU29). The
two lysine residues K16 and K28 are shown in red stick structures. In fibril model, the
first 10 N-terminal residues are omitted, because they are structurally disordered and
exposed along the fibril surface. The structures were generated using UCSF Chimera37.
In this study, three different acetylation modified Aβ42 peptides were synthesized:
single acetylation on K16 (K16Ac) or K28 (K28Ac), or double acetylation on both
Lysine residues (KKAc). We found that the acetylation on K28 slows down the
fibrillization process of Aβ42, but still promotes a fibril-like structure. However sidechain acetylation on K16 can profoundly impair the fibrillization property and
significantly affect toxicity of Aβ42 peptide, which could account for the modulation of
Aβ42 related pathogenic.

4.2 Materials and methods
Prepare amyloid β peptide assembly samples – Synthetic wild-type (WT), K16Ac,
K28Ac, and KKAc Aβ42 peptides were purchased from Biomatik (Canada). The identity
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and purity (>95%) of all four peptides were confirmed by mass spectrometry and RPHPLC. Preparation of aggregate-free monomers followed the method from Teplow et al.
201338. In brief, the peptide lyophilizate was first dissolved in 10% (v/v) of 60 mM
NaOH, followed by 45% (v/v) MilliQ water. The the pH was adjusted by adding 45%
(v/v) of 10 mM sodium phosphate buffer (pH 7.4). After 10 min centrigufe at 16,000 × g
at 4 oC, the supernatant fluid was filted through 0.22 μm membrane. Concentration of
peptide stock was determined using ε214 = 75,887 M-1cm-1. All the solutions and MilliQ
water were filtered through 0.22 μm membrane before use. Peptide stocks were stored at
-80 oC until use.
Thioflavin T (ThT) fluorescence – Fluorescence measurements were performed on
Horiba Jobin Yvon spectrofluorometer (Fluoromax-4) at room temperature as previously
described in chapter 2. In brief, Samples (50 μM peptide in 50 mM phosphate buffer, 300
mM NaCl, pH 7.4) were incubated at 37 oC with agitation for indicated time. After
incubation, samples were diluted by phosphate buffer (10 mM, pH 7.4) to a final
concentration of 10 μM, followed by addition of ThT solutions (final concentration at 10
μM). Emission spectra were collected at room temperature from 460 – 700 nm, with
excitation at 450 nm.
8-anilino-1-naphthalenesulfoni acid (ANS) fluorescence – Freshly prepared samples
and 7-day fibril/aggregates samples that contain 10 μM peptides were mixed with ANS
solution (final concentration at 10 μM). Emission spectra were collected at room
temperature from 400 – 700 nm, with excitation at 380 nm.
Field emission scanning electron microscopy (FESEM) – FESEM images were
acquired on a Hitachi S-4700 FESEM microscope as previous described in chapter 2. In
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brief, samples were pelleted by centrifuging at 9,000 × g for 45 min at room temperature.
To wash off salts, the pellets were separated and suspended in MilliQ water (0.22 μm
membrane filtered) and centrifuged at 9,000 × g for 45 min at room temperature. Washed
fibrils or aggregates were applied on SEM stubs and air dried at room temperature. The
SEM samples were then coated with 10 nm platinum. For FESEM imaging, 10 kV of
acceleration voltage and 5 μA of emission current were used.
Molecular dynamics (MD) calculations – Docking calculations were carried out
using AutoDock Vina (Vina)39 and DrugScore eXtended (DSX)40. The 3D configuration
of ANS is downloaded from PubChem database and saved as PDB file. The energetically
most stable Aβ42 configuration proposed by 1Z0Q36 PDB file is used as WT template.
Mutator Plugin of the VMD41 was applied to perform in silico acetylation of Lysine
residues. PDB files for WT, K16Ac, K28Ac and KKAc Aβ42 were created. The ANSAβ42 complexes are refined VMD 1.9.241. The initial topology and parameter files for
Acetylated Lysine (ALY) and ANS are created by SwissParam Web Server42. The
atomic charges on the topology files are refined by B3LYP level QM calculations using
Gaussian 09 Revision D.0143. The molecular simulations to minimize the energy of the
ligand-protein complexes were performed in the canonical (NVT) ensemble with periodic
boundary conditions in all three directions. The iteration was stopped after 10,000 time
steps and the resultant geometries were recorded. ANS was re-docked on the resultant
Aβ42 PDB file and the Vina scores were recorded. The docking output by Vina and the
backbone proteins were then used as input files for DSX. The z scores (standard scores)
were calculated using the equation:
𝑧𝑧 =

𝑥𝑥 − 𝜇𝜇
𝜎𝜎
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Where x is the raw score, μ is the population mean and σ is the standard deviation of
the population.
The resultant PDB files for different ANS-Aβ42 complexes are submitted to the
PLIP (Protein Ligand Interaction Profiler)44 Web Server based on a Python command line
application and an empirical database of non-covalent interactions44. The interactions are
visualized by JSMol applet embedded in the Web Server. Whole molecule is
encapsulated by AutoDock Grid Box since no binding region is proposed prior to the
calculations. The docking results are listed with respect to the scoring function and
visualized by UCSF Chimera37.
Cell viability (MTS) assay – SH-SY5Y human neuroblastoma cells (from ATCC)
were cultured in DMEM/F-12 medium with 10% FBS and 100 U/ml penicillinstreptomycin at 37 oC in 5% CO2 humidified environment and used within the first 10
passages. Cells were plated at 2 × 104 cells/well on 96-well plates and allowed to grow
overnight. The next day, the culture media were removed and cells were washed with 1X
PBS buffer (pH 7.4) twice. Then 100 μl fresh media containing 1, 2, or 5 μM of peptide
samples were added to each well. Six replicates were prepared for each sample. Media
without any peptide were used as controls. After 48 h incubation, 20 μl of CellTiter 96®
AQueous One Solution Cell Proliferation (MTS) Assay kit (Promega) were added to each
well and incubated for 4 h. Then absorbance at 490 nm were collected using an ELISA
plate reader (BioTek Instruments, Inc.). Blanks containing media and peptide samples but
no cells were similarly prepared and used for background subtraction.
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4.3 Results
Surface hydrophobicity of wild type (WT) Aβ42 peptide and the three acetylationmodified peptides were measured by ANS fluorescence (Figure 4.2A). Even though
freshly prepared peptides displayed very similar ANS fluorescence, all three acetylated
peptides showed slightly higher fluorescence than WT. For better understanding of the
results, the resultant geometries by NAMD calculations were optimized and ANS
docking was remolded. The final Binding Affinities and ligand-protein interactions are
used to interpret the experimental findings. The top-ranked poses of ANS at all four
Aβ42 forms have one common major binding site: hydrophobic rings of ANS interact
with the aromatic rings of Y10 and H14; the negative charge from ANS is paired with the
positive charge on H14 (Figure 4.3). Two more potential binding sites were observed
(Figure 4.3): the hydrophobic pocket which is known to play an important role in the
aggregation (16-21) and also the region near C terminus (30-35). Table 4.1 and 4.2 show
the docking scores of ANS on the four peptides, calculated using DSX and AutoDock
Vina. Although the docking scores of Y10 & H14 site are very close in all four peptides
(Table 4.1), the ANS binding in the central hydrophobic core (17-20) was strongly
affected by acetylation on K16 (Table 4.1, Figure 4.3). With K16Ac, ANS docking scores
are -39.132 kcal/mol and -5.0 kcal/mol by DSX and AutoDock Vina, respectively, which
are significantly lower than other peptides (Table 4.1). That indicates a significant
increase in the hydrophobicity of the 16-21 core, which is related to ANS fluorescence
(Figure 4.2A). After 7 days of incubation, differences of hydrophobicity among the four
peptides were amplified, especially in K16Ac and KKAc (Figure 4.2A). It is noticeable
that fluorescence intensity of K16Ac is almost doubled after incubation for 7 days.
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K28Ac showed results similar to WT peptide. Since the Aβ peptides normally appear in
the brain in the heterozygous state, 1:1 ratio mixtures of WT Aβ42 with each acetylated
peptide were prepared. The hydrophobicity of aggregates generated from the mixtures
showed a slight increase in fluorescence compared to WT peptides, except for K28Ac
and WT mixture (Figure 4.2A).
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Figure 4.2. (A) Hydrophobicity of the fresh Aβ42 peptides and the 7-day
fibril/aggregates were measured by ANS fluorescence. Ten μM of peptide samples were
incubated with 10 μM of ANS. Mix represents the 1:1 mixture of the acetylated peptide
with WT as shown on the right side of the panel. Error bars = ± S.D. (B) The most stable
binding conformer of ANS and Aβ42 peptide analyzed by PLIP44. Peptide backbones are
in green, ANS molecule is in red, and the major binding sites Y10&H14 are labeled in
blue.
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Figure 4.3. The three potential binding sites, Y10&H14, 16-21 region, and 30-35
region, on WT, K16Ac, K28Ac, and KKAc Aβ42.
Table 4.1 Docking scores (in kcal/mol) of ANS on the sites Y10 & H14
Y10 & H14
DSX Score

ZDSX

AutoDock Vina Score

Zvina

WT

-12.386

-1.12

-6.1

-2.48

K16Ac

-12.311

-1.74

-6.1

-1.96

K28Ac

-12.312

-1.39

-6.1

-2.04

KKAc

-12.339

-1.47

-6.1

-2.18

Table 4.2 Docking scores (in kcal/mol) of ANS on region 16-21
region 16-21
DSX Score

ZDSX

AutoDock Vina Score

Zvina

WT

-14.250

0.44

-4.7

0.1

K16Ac

-39.132

-1.50

-5.0

-1.1

K28Ac

-12.975

-0.54

-4.4

1.3

KKAc

-13.284

0.52

-4.8

-0.3
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Fibrillization/aggregation of the four peptides were monitored by ThT fluorescence
(Figure 4.4 A-D). The K28Ac peptide showed very similar sigmoidal fluorescence trend
with WT Aβ42 and was able to form fibril-like structures in both homogenous K28Ac
sample (Figure 4.4 A, G) and the equimolar mixture with WT (Figure 3C, J). In sharp
contrast, the two peptides that have acetylation on K16 (K16Ac and KKAc) both showed
non-sigmoidal ThT fluorescence trend (Figure 3A) and formed amorphous aggregates
after 7 days (Figure 4.4 F, H) and even 14 days (Figure 4.5). Noticeably, even though
KKAc did not form amyloid fibrils (Figure 3 H), it showed high ThT fluorescence
intensity (Figure 4.4A). The aggregation processes of the 1:1 mixtures with WT showed
that K16Ac and KKAc maintained their aggregation properties in presence of WT Aβ42,
and only amorphous aggregates were observed after incubation (Figure 4.4 B, D, J, L).
These results suggest that acetylation on K16 position can significantly affect the
fibrillization process of Aβ42 peptide. Interestingly, even though the aggregates formed
from the mixtures of K16Ac and KKAc were still amorphous, their morphologies were
different from pure K16Ac or KKAc aggregates, also showing reduced bis-ANS
fluorescence (Figure 4.4 I).
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Figure 4.4. Fibrillization/aggregation of WT and acetylated peptides was monitored
using ThT fluorescence, bis-ANS fluorescence, and SEM. For ThT fluorescence analysis
(A-D), 10 μM of peptide samples were incubates with 10 μM of ThT. Peak intensities at
487 nm were plotted in function of time. After 7 days incubation, the structures of fibrils
or aggregates were visualized using SEM (E-K). Scale bars are 1 μm for all. Structure
flexibility of the fibrils or aggregates were measured by bis-ANS fluorescence (I). Error
bars = ± S.D.
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Figure 4.5. SEM images of samples after 14 days incubation. Scale bars are 5 μm, 1
μm and 500 nm for top panel to bottom panels, respectively.
Cell viability of Aβ42 fibrils and aggregates were determined using using human
HUVEC-C endothelial cells and SH-SY5Y neuroblastoma cells (Figure 4.6). At 2 μM,
the WT fibrils and K16Ac aggregates were found harmful to normal cells (HUVEC-C)
after 72 h (Figure 4.6). The rigid amorphous aggregates formed from the equal molar
mixture of WT and K16Ac showed severe cytotoxicity (Figure 4.6). However, for SHSY5Y cells, the fresh K16Ac showed the highest cytotoxicity, whereas its 7-day
aggregates resulted in >80% cell viability. All the 72 h samples of WT and single
acetylated peptides were found to be more harmful to neuroblastoma cells than the 7-day
aggregates. Interestingly, for KKAc, the fresh peptide was protective but 7-day aggregate
showed severe toxicity. Interestingly, the cell viability decreased in all three mixtures,
especially the K16Ac mixture, showing 20% decrease in 7-day samples.
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Figure 4.6. Cell viability of HUVEC-C cells and SH-SY5Y cells with Aβ42 fibrils
or aggregates. The WT or acetylated Aβ42 peptides were incubated at pH 7.4 and 37 oC
for 0 h, 72 h, or 7 d, and then added to cells to a final concentration of 2 μM. The
mixtures represent samples containing equimolar WT and acetylated peptides. Error bars
= ± S.D.

4.4 Discussion
Amyloid fibril dynamics could be affected by the chemical nature of the Aβ peptide
through side-chain interactions45. Here we demonstrated that acetylation on lysine 16 and
28 have distinct effects on Aβ42 fibril formation. Acetylation on K16 is more essential to
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the early stage inter-peptide interactions, which disrupted fibril formation and altered the
related cytotoxicity.
In this study, acetylation on both K16 and K28 residues was expected to affect the
hydrophobicity of Aβ42, since these are located near hydrophobic patches. While
negligible differences of ANS fluorescence was observed between WT and the acetylated
peptides. PLIP analysis showed that the major binding site of hydrophobic probe ANS is
Y10 & H14 and not the central hydrophobic core, L17-F20 (Figure 4.2, Table 4.1 and
4.2). However, K16 acetylation increased the binding affinity of ANS in the 16-20 region
of both K16Ac and KKAc peptides, which later formed amorphous aggregates with
higher hydrophobicity than amyloid fibrils (Figure 4.2).
The aggregation rate of K16Ac peptide was faster than K28Ac and WT peptide,
showing a slightly greater slope in the first 2 days (Figure 4.4A, 4.5). Moreover,
aggregation of K16Ac peptides completed in 2 days, which is almost the same as the lag
time of WT and K28Ac peptides (Figure 4.4A). Similar rapid aggregation without lag
time was previously observed in computational simulation of Aβ16-22 fragment, in
which the Aβ16-22 peptide oligomers were found to be in a disordered molten globular
structure as a result of strong hydrophobic interactions46. As the oligomers undergo
conformational reorganization, anti-parallel β-sheet structure form and was stabilized by
inter-chain salt bridges between K16 and E2247, which follows the “dock-lock”
mechanism of fibril growth. During fibril formation, the addition of Aβ monomers to
fibril template is a sequential process of two distinct kinetic steps. In the first step, dock,
Aβ monomers bind to fibril (or fibril template) rapidly and fully reversibly. In the second
step, lock, the deposited monomer undergoes conformational reorganization, which
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significantly increased its association affinity to fibril, resulting in irreversible binding. It
was also proposed that the formation of ordered amyloid fibril or oligomer structures
could be affected by the competition of hydrophobic interactions and hydrogen bonding,
as the higher ordered structures, protofibrils and mature fibrils, are stabilized by high
density of direct inter-chain hydrogen bonds and steric zipper interactions46, 48. According
to the dock-lock mechanism, although the formation of amyloid fibrils is
thermaodynamically favored, the transition from monomers to amyloid conformations is
kinetically limited47. Considering that the 16-20 residues (KLVFF) was previously
detected as a intermolecular binding sequence of Aβ40 fibrillization28, in case of K16Ac
aggregation, it is possible that the inter-chain hydrophobic interactions of the residues 1620 increased after removing the positive charge on K16, resulting in the initial rapid
docking process becoming irreversible, which kinetically inhibited the conformational
reorganization in the locking phase (Figure 4.7). As a consequence, K16Ac was able to
inhibit amyloid fibril formation of WT Aβ42 in their equimolar mixture (Figure 4.4C).
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Figure 4.7. Suggested schematic model based on the aggregation results of WT and
acetylation modified Aβ42 peptides. Both WT and K28Ac Aβ42 peptide formed amyloid
fibril structures. Acetylation on K28 may cause formation of a different type of fibril,
probably due to loss of the K28-A42 salt bridge, but does not show any critical effects on
morphology. Acetylation on K16 possibly increased the binding affinity of the K16-F20
region (green), which serves as intermolecular binding sequence during Aβ42
fibrillization. In consequence, aggregation was kinetically driven to form amorphous
aggregates.
The Aβ42 mature fibrils were recently found to form an S-shape “triple-β-motif”29
(Figure 4.1), which is different from the U-shape conformation of Aβ40 fibrils (Figure
A3). The D23-K28 salt bridge, which was previously found to be essential in Aβ40
fibrils30, 49, 50, was missing in the Aβ42 fibril structure; instead, a unique salt bridge was
observed between K28 and A4229. After removing the positive charge on K28 by
acetylation, the K28Ac peptide has a longer lag time than WT Aβ42 peptide during
aggregation. This confirms the stabilizing role of K28-A42 during the early-stage
conformational changes for nucleation51. However, the K28Ac peptides were capable of
forming amyloid fibril structures eventually, no matter in homogeneous K28Ac peptide
sample, or in a heterogeneous equimolar mixture with WT Aβ42 (Figure 4.4A, C, G, J).
This suggests that the salt bridge may not be essential to fibril morphology. N-ε-amino
acetylation on K28 was previously done on Aβ25-35 fragment, and the gross structure of
Aβ25-35-K28Ac fibril was very similar with WT Aβ25-35 fibrils27. The K28Ac fibrils
observed here may probably have a U-shape structure, which is different with the S-shape
fibril of WT Aβ42. Acetylation on K28 may alter the triple-β conformation by
interrupting the K28-A42 salt bridge, and slowdown the early-stage misfolding and
nucleation. However, it did not show significant effect on morphology or cytotoxicity of
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Aβ42 fibrils. The amorphous aggregates formed from KKAc (Figure 4.4H, K) suggest
that the K16 is probably more critical to Aβ42 fibrillization than K28.
Compared to other posttranslational modified Aβ12,

15, 16

, the K16Ac and K28Ac

peptides were not deleterious to the SH-SY5Y cells, exhibiting similar or less cell loss
than WT Aβ42 fibrils of 72 h oligomers and 7-day aggregates, respectively (Figure 4.6).
Interestingly, the K16Ac peptide that added to cells as fresh monomers showed much less
increased toxicity compared to other forms after 48 h incubation. It was recently noticed
that the early species in aggregation are more toxic than the final aggregates or fibrils52.
However, toxicity of KKAc peptide increased with longer incubation (7 d) and fresh
peptide shows very mild damage to cells. Although both K16Ac and KKAc aggregates
are amorphous, the K16Ac aggregates are defined bead-like structures compared to
KKAc. The different toxicities of these two peptides may be related to their structural
variations. Another hypothesis suggests that the cytotoxicity is due to the dynamic
aggregation process, rather than any single structure species10,

52

. Minor shifts in the

Aβ40:Aβ42 ratio was demonstrated to be enough to modulate neurotoxicity5. In addition,
the K16N mutation of Aβ42 is not harmful in isolation, but exhibits severe toxicity when
mixed with WT peptides32. Whereas the mixture of WT Aβ42 and its toxic mutation A2V
was protective to the cells, both in vitro and in vivo53. Here in this study, the aggregates
formed from heterogeneous mixtures of WT and acetylate peptides all showed increased
toxicity compared to homogeneous samples. Therefore, in addition to the structural
characteristics, the dynamic interactions of different species contribute significantly to
aggregation related toxicity.
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4.5 Conclusion
In the present study, the Aβ42 peptide was modified with lysine side-chain
acetylation on residues K16 and K28. Acetylation on K16 position can significantly
affect the hydrophobicity of residues K16-A21 and alter the Aβ42 self-assembly resulting
in formation of amorphous aggregates instead of amyloid fibril. This switch is probably
kinetically driven by the increased inter-peptide hydrophobic interactions in the K16-A21
region. The peptides with single acetylation on K28 can still assemble into typical
amyloid fibrils, confirmed by ThT fluorescence and SEM images. However, the
amorphous aggregates formed from heterogeneous mixtures of WT and acetylated
peptides exhibit severe cytotoxicity to SH-SY5Y cells, indicating the dynamics of Aβ42
aggregation needs to be explored further in future studies.
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5.1 Introduction
Abnormal

protein

folding

and

aggregations

are

constantly

observed

in

neurodegenerative diseases and are believed to be pathogenic1-4. In these diseases, the
intracellular or extracellular accumulation of protein aggregates could be amyloid fibrils
or amorphous structures, resulting from mutations or post-translational modifications of
the disease-related proteins, or triggered by environmental stress5. Moreover, proteins
that do not cause amyloid diseases are also able to form toxic aggregates3, 6. Although the
literature has many reported studies that focus on amyloid fibrils, which are commonly
observed in human diseases; recently, there has been a surge in numbers of pre-fibril
oligomers and amorphous aggregates studies reported in the literature7-11. Unlike amyloid
fibrils, the non-fibril structures (amorphous) have very low stability, which limits high
resolution structure determination using NMR or X-ray crystallography technique.
The toxicity of protein aggregates could be a consequence of losing the normal
functions, sequestration, mislocalizations, or gain of toxic function12. However, after
decades of searching, the predominant toxic species in amyloid diseases is still remains
unclear. Amyloids were found to disrupt cellular structure and function because of their
large sizes13. However, only weak correlations were observed between the clinical
severity of the diseases and the density of amyloid plaques or inclusion bodies formed
from protein fibrils14-16. Increasing evidences indicated that the amyloid formation could
be a consequence of cellular protective response1. Some amyloids have no toxicity but
biological functions, such as binding of peptide hormones, formation of biofilms, or
launch of innate immune responses4, 17-19. On the other hand, small non-fibril oligomers
and many other amorphous aggregates were recently proposed to be the major toxic
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species in human diseases7,

8, 20

. Many soluble oligomers of amyloid β peptide were

isolated from Alzheimer’s disease brain, causing severe synaptic toxicity both in vitro
and in vivo21, 22. In addition, in vitro cell culture models of Parkinson’s disease also
showed that co-transfection of α-synuclein and its interacting protein in cells could
enhance the formation of inclusion bodies and cell viability23, 24. Therefore, the early
events of aggregation might cause toxicity, while the formation of mature fibril structures
only represent the end-stage manifestation1. To better understand the cellular toxic
mechanism in the amyloidosis diseases, more information of the biochemistry and
biophysics of the non-fibril structures, such as oligomers, protofibrils, and amorphous
aggregates, will be critical. Many non-fibril oligomer or amorphous structures in previous
studies have similar properties. Unfortunately, different laboratories in the field normally
do not share or compare their protein aggregates.
In this study, different protein aggregates structures selected from previous reports
were prepared and compared for their size, flexibility, hydrophobicity, and cytotoxicity.
The goal is to characterize the differences of amorphous aggregates and correlate it to
cytotoxicity. This will help to understand the relationship between different
morphological structures and their toxicity.

5.2 Materials and methods
Unless otherwise indicated, all materials were used as supplied by the manufacturer
without any further purification. Hen egg white lysozyme (lysozyme), bovine serum
albumin

(BSA),

dithiothreitol

(DTT),

Thioflavin

T

(ThT),

8-anilino-1-

naphthalenesulfonic acid (ANS) dye, 4,4’-Dianilino-1,1’-binaphthyl-5,5’-disulfonic acid
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(bis-ANS) dye, 2',7'-dichlorofluorescin diacetate (DCFH-DA) were purchased from
Sigma. The CellTiter 96® AQueous One Solution Cell Proliferation (MTS) Assay kit was
from Promega.
Preparing protein fibrils/aggregates – Fibrils/aggregates were prepared using
method from the following studies listed in Table 5.1 and 5.2.
Table 5.1. Sample preparation conditions of lysozyme aggregates
Sample # structure
I

Amyloid

condition
Samples contain 1 mM lysozyme in HCl solution (pH 2.0)
were incubated at 65 oC for 7 days25
Samples contain 140 uM lysozyme in HCl solution (pH

II

Amorphous

2.0, with 136.7 mM NaCl, 2.68 mM KCl, and 4 mM

aggregates

DTT). Samples were first mixed via vortex and then
incubated were incubated at 55 oC for 30 days26

III

IV &V

VI

VII

Amorphous
aggregates

Amorphous
aggregates

Samples contain 40 μM lysozyme in phosphate buffer (pH
7.2, 20 mM, with 150 mM NaCl) were incubated at 37 oC
for 7 days11
Samples contain 699 μM lysozyme in Phosphate buffer
(pH 7.4, 100 mM) were incubated at 56 oC (IV) and 25
o

C (V) 27

Amorphous

Samples contain 120 µM lysozyme in Phosphate buffer

aggregates

(pH 7.0, 50 mM) were incubated at 25 oC28

Amorphous

Samples contain 120 µM lysozyme in Phosphate-NaOH

aggregates

buffer (pH 12.0, 50 mM) were incubated at 25 oC28

Table 5.2. Sample preparation conditions of BSA aggregates
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Sample #

structure

condition
Samples contain 100 µM BSA in glycine-HCl buffer (pH

I

Amorphous

3.0, 50 mM , with 50 mM NaCl) were incubated at 65 oC
for 4 h then followed by 30 days room temperature
incubation29

II

III

IV

Amorphous
aggregates

protofibrils

Samples contain 40 μM BSA in phosphate buffer (pH 7.2,
20 mM, with 150 mM NaCl) were incubated at 37 oC for 7
days11
Samples contain 37.6 μM BSA in Tris–HCl buffer (pH 7.4,
20 mM) were incubated at 70 oC for 4 days30

Amorphous Samples contain 7.5 uM BSA in phosphate buffer (pH 8.9,
aggregates

0.1 M) were incubated at 62 oC over 10 h31

Fluorescence measurements – Fluorescence measurements were performed as
previously described in chapter 2. In brief, samples were diluted by phosphate buffer (10
mM, pH 7.4) to a final concentration of 10 μM. Fluorescent probes Thioflavin T (ThT),
8-anilino-1-naphthalenesulfoni acid (ANS), and 4,4'-dianilino-1,1'-binaphthyl-5,5'disulfonic acid (bis-ANS) were prepared in ethonal and then added to samples to final
concentrations of 10 μM (ThT), 5 μM (ANS), and 1 μM (bis-ANS). Emission spectra
were collected using a Horiba Hobin Yvon spectrofluorometer (Fluoromax-4) at room
temperature. ThT spectra were collected from 460 – 700 nm, with excitation at 450 nm.
ANS and bis-ANS spectra were acquired from 400 – 700 nm, with excitation at 380 nm
and 360 nm, respectively.
Field emission scanning electron microscopy (FESEM) – Protein samples were
analyzed using a cold field emission high-resolution scanning electron microscope,
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Hitachi S-4700 FESEM as previously described in chapter 2. In brief, protein samples
were washed in MilliQ water using a Millipore Amicon® Ultra centrifugal filters (3 kDa
cut off) by centrifuging three times at 7,000 × g for 30 min at 4 oC. Washed fibrils or
aggregates were applied on SEM stubs and air dried at room temperature. The SEM
samples were then coated with 10 nm platinum. For FESEM imaging, 10 kV of
acceleration voltage and 5 μA of emission current were used.
Cell viability (MTS) assay – SH-SY5Y human neuroblastoma cells (from ATCC)
were cultured in DMEM/F-12 medium with 10% FBS and 100 U/ml penicillinstreptomycin at 37 oC in 5% CO2 humidified environment and used within the first 10
passages. Cells were plated at 2 × 104 cells/well on 96-well plates and allowed to grow
overnight. The next day, cells were washed with 1X PBS buffer (pH 7.4) twice. Then 100
μl fresh media containing peptide samples were added. Six replicates were prepared per
sample. Media without any peptide were used as controls. After 48 h incubation, 20 μl of
CellTiter 96® AQueous One Solution Cell Proliferation (MTS) Assay kit (Promega)
were added and incubated for 4 h. Then absorbance at 490 nm were collected using an
ELISA plate reader (BioTek Instruments, Inc.). Blanks containing media and peptide
samples but no cells were similarly prepared and used for background subtraction.
Cytotoxicity (LDH) assay – SH-SY5Y cells were plated at 2 × 104 cells/well on 96well plates and incubated with protein aggregate samples for 48 h. After incubation, 50 μl
of aliquots from each test and control well was transferred to a fresh 96-well plate. To
prepare positive control that has maximum lactate dehydrogenase (LDH) release, 10 μl of
10X lysis solution were added into each well and incubated for 45 min. Then 50 μl of
reagent from the CytoTox 96® Non-Radioactive Cytosocity Assay kit (Promega) were
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added and incubated for 30 min, followed by addition of 50 μl stop solution. The
absorbance at 490 nm were collected using an ELISA plate reader (BioTek Instruments,
Inc.). Blanks containing media and peptide samples but no cells were similarly prepared
and used for background subtraction.
2',7'-dichlorofluorescin diacetate (DCFH-DA) fluorescence assay – Intracellular
reactive oxidative species (ROS) can oxidize DCFH-DA to the highly fluorescent
compound dichlorofluorescein (DCF).Therefore, respiratory burst activity in cells was
detected by using the fluorescent probe DCFH-DA32, 33. DCFH-DA was dissolved in
ethanol at 25 mM as tock solution. SH-SY5Y cells were seeded in 96-well plates at 1 x
105 cells/well and were incubated with protein aggregate samples for 24 h. After
incubation, cells were washed using 1X PBS and then incubated with 10 μM DCFH-DA
at 37 oC for 30 min, then washed with 1X PBS. The fluorescence intensity of DCF was
measured in a Multiskan™ GO Microplate Spectrophotometer (Thermo Scientific) at
excitation wavelength 485 nm and emission wavelength 538 nm.

5.3 Results and discussion
In this study, three fluorescent probes were used to characterize the protein
aggregates. As introduced in chapter 2, ANS dye detects hydrophobic structures or
nonpolar cavities in proteins with high fluorescence signals. The dimeric analogue of
ANS, bis-ANS, is an important probe to determine structure flexibility. ThT was used to
detect the structural property of the aggregates. From the previous publications11, 25-29, 31,
34

, a total of 17 samples at different conditions were selected (Table S1). However, we

found that at the same pH and temperature, changes in concentration with 100 μM did not
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have significant effects on protein structure and related fluorescence analysis (Figure 5.1).
Therefore, only one concentration at each set of condition was selected as the most
representative samples for toxicity measurements.
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Figure 5.1. Samples at same pH and temperature but different concentrations
showed similar ANS, bis-ANS, and ThT fluorescence results. (A, B) Samples that
contain 80 μM (A) or 120 μM (B) of lysozyme at pH 7.0 were incubated at 25 oC up to
14 days. (C, D, E) Samples that contain 40 μM (C), 80 μM (D) or 120 μM (E) of
lysozyme at pH 12.0 were incubated at 25 oC up to 14 days.
First, we compared different types of aggregates, amyloid and granular structures,
from the same proteins (Figure 5.2 and 5.3). Figure 5.2 shows three different aggregate
structures generated from lysozyme. The fibril structure showed increased ANS and ThT
fluorescence and decreased cell viability upon incubation (Figure 5.2 A, D). This is in
line with a previous hypothesis that the extracellular amyloid deposits can physically
disrupt the cellular structure and function by a bulk process1. While the other two
amorphous aggregates had more hydrophobic and flexible structures than the fibrils, but
did not bind to ThT (Figure 5.2 B, C). Even though both amorphous aggregates had a
granular appearance when observed under SEM, aggregate II (Figure 5.2 B) had a
smaller subunit size, which results in a more rigid structure. Unlike fibrils, both granular
aggregates were most harmful to the cell after 12h incubation, suggesting that under these
two conditions, the aggregation intermediates were more toxic. Interestingly, both 12 h
and 7 d samples of aggregate III (Figure 5.2 C) resulted in < 40% cell viability, but the 3
d sample showed decreased toxic. Except ThT fluorescence, the aggregate III showed
negligible changes in hydrophobicity, flexibility, and overall morphology after 12 h.
According to a previous study11, the amount of high molecular species increased from 12
h to 7 d, suggesting that although negligible changes were observed for fluorescence and
morphology (Figure 5.2 and B1), the aggregation was still continuing, to form larger
protein assemblies. Therefore, the 7d sample had most mature aggregates, while the 12 h
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sample contains both intermediates and mature aggregates, the toxicity of 12 h samples is
likely due to the heterogeneity of sample.
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Figure 5.2. Three different structures generated from lysozyme were characterized
using fluorescent probes, SEM, and MTS assay. (A) Fluorescence results and SEM image
of lysozyme aggregate I: amyloid fibril generated from 1 mM lysozyme at pH 2.0, 65 oC.
(B) Fluorescence results and SEM image of lysozyme aggregate II: amorphous aggregate
generated from 140 μM lysozyme at pH 2.0, 55 oC. (C) Fluorescence results and SEM
image of lysozyme aggregate III: amorphous aggregate generated from 40 μM lysozyme
with 10 mM DTT at pH 7.2, 37 oC. (D) MTS assay of SH-SY5Y cells incubated with 15
μM lysozyme aggregates I-III. Error bars = ± S.D. Scale bars in SEM images = 5 μm.
For BSA, all four aggregates tested here did not show any detectable changes of bisANS fluorescence. This may be due to the bulky nature of the BSA protein. The BSA_I
(Figure 5.3A) showed negligible changes for up to 30 days of incubation, but two types
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of structures, granular and fibril-like, were observed under SEM. However, these
aggregates from BSA_I samples appear to be essentially harmless to the SH-SY5Y cell
(Figure 5.3 E). During aggregation, BSA_II, III, and IV showed different levels of
impairments of ANS fluorescence and increases in ThT fluorescence. Even though
BSA_IV aggregates appeared in straight fibril-like morphology, we found that the
structure could not bind ThT, and was very unstable under SEM, suggesting that this
structure might not be classified as amyloid fibrils. Cytotoxicity of the two non-fibril
aggregates, BSA_II and IV followed similar trends as their ANS fluorescence, where
toxicity of BSA_II aggregates stayed stable after 12 h, but the number of live cell treated
by BSA_IV samples kept decreasing till 7 d (Figure 5.3 B, D, E). Since a decrease of
ANS fluorescence indicates conformational change and assembly of BSA molecules, the
matched trends of the toxicity and ANS results suggests that the final aggregates are the
major toxic species in these two cases. For BSA_III, the high ThT fluorescence signals
and the short fibrillar structures (Figure 5.3 C) identified this structure as protofibrils.
Both the 2 h intermediates and the 7d protofibrils of BSA_III caused impairment of cell
viability (Figure 5.3E). Since the 12 h intermediates were more hydrophobic and less
stable than the 7 d protofibrils (Figure S5.2), they might cause cell dysfunction or death
through different mechanisms.
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Figure 5.3. Four different structures generated from BSA were characterized using
fluorescent probes, SEM, and MTS assay. (A) Fluorescence results and SEM image of
BSA_I aggregate: amorphous aggregate mixed with fibril-like structures generated from
100 μM BSA at pH 3.0, 25 oC. (B) Fluorescence results and SEM image of BSA
aggregate II: amorphous aggregate generated from 40 μM BSA with 10 mM DTT at pH
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7.2, 37 oC. (C) Fluorescence results and SEM image of BSA aggregate III: protofibril
generated from 37.6 μM BSA at pH 7.4, 70 oC. (D) Fluorescence results and SEM image
of BSA aggregate IV: amorphous aggregate generated from 7.5 μM of BSA at pH 8.9, 65
o

C. (E) MTS assay of SH-SY5Y cells incubated with 15 μM BSA aggregates I-IV. Error

bars = ± S.D. Scale bars in SEM images = 1 μm (A-C) or 10 μm (D).
There is an ongoing debate in the field, as to what is the primary toxic species
responsible for diseases5, 7, 35, 36. Many protein aggregate toxicity studies have shown that
the rapidly formed non-fibril oligomers are more toxic than the highly organized fibrillar
structures, which may be due to the exposure of hydrophobic side chains7,

35, 36

.

Interestingly, we observed that the granular BSA_II aggregates showed a similar trend in
the toxicity as lysozyme_I fibrils, where all aggregates from 12 h to 7 d had a similar
level of cytotoxicity (Figure 5.3E and 5.2D). In addition, the protofibrils from BSA_III
and the granular lysozyme_III aggregates both have toxic intermediates as well as toxic
mature aggregates (Figure 5.3 C and 5.2 A). According to our observations of different
protein aggregates from lysozyme and BSA, the toxic species may not be conclude as
general fibrillar or granular structures. While the only sample that did not exhibit any
toxicity, was BSA_I, which showed two different structures but no measurable changes
in fluorescence. This suggest that the aggregate toxicity may not depend on the overall
appearance of the structure, but depend on the molecular organization of the aggregates35.
Next, we prepared four different non-fibrillar aggregate structures that are all in
granular appearance from the same protein, lysozyme (Figure 5.4). Although generated
under very different conditions (see Table 5.1), similar morphology and subunit size of
the aggregates were observed. The four aggregates could be grouped as two pairs that
lysozyme_IV and VI forms larger bead-like structures, while lysozyme_V and VII forms
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smaller and more compact structures. Does size matter? In general, although size
measurements may lack structural/conformational details, size could matter for the
activity of small structures in 10-100 kDa, or the insoluble ones8. Smaller size would be
expected to assist diffusion, and could provide larger surface to mass ratio for potential
interactions. However, here among the four granular aggregates, structures that have the
largest (Lysozyme_IV) and the smallest (Lysozyme_VII) unit size caused impairment of
cell viability (Figure 5.4 E), indicating that size dose not play a primary role to affect
cytotoxicity. It is noticeable that the non-toxic structures did not show any measurable
changes in ANS, bis-ANS, or ThT fluorescence (Figure 5.4 B, C), which is very similar
with BSA_I (Figure 5.3A). These results again support the idea that toxicity closely
related to the conformational organization of protein aggregates. Interestingly, proteins
formed non-toxic aggregates without significant conformational changes. Although these
aggregates were stable and large, they stayed as harmless as the native monomers.
Therefore, conformational rearrangement is probably the first step to gain toxicity.
However, the toxic aggregates observed so far present a mixed picture: in general, the
results support that the toxicity may likely be a consequence of the loss of protein’s
native fold, but whether the observed cytotoxicity specifically associated with one certain
structure/conformation or it is a consequence of general heterogeneous dynamic of the
aggregation process still remains to be clarified.

153

154

Figure 5.4. Four different bead-like amorphous aggregate structures generated from
lysozyme were characterized using fluorescent probes, SEM, and MTS assay. (A, B)
Fluorescence results and SEM image of lysozyme aggregate IV (A) and V (B): generated
from 699 μM lysozyme at pH 7.4, 65 oC (A) or 25 oC (B). (C) Fluorescence results and
SEM image of lysozyme aggregate VI: generated from 120 μM lysozyme at pH 7.0, 25
o

C. (D) Fluorescence results and SEM image of lysozyme aggregate VII: generated from
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120 μM lysozyme at pH 12.0, 25 oC. (D) MTS assay of of SH-SY5Y cells incubated with
15 μM lysozyme aggregates IV-VII. Error bars = ± S.D. Scale bars in SEM images = 1
μm.
Similar results have also been reported in studies of other proteins35, such as αsynuclein37, amyloid β peptide38, 39, and Hyp-F peptide40. Many of these on-/off-pathway
aggregates share similar morphologies or overlapping properties, but different toxic
effects36. It has been proposed that the increase toxicity of certain protein assemblies is
due to their “biologically active conformation”38, which exposes the “toxic surface”1 on
the molecules. However, the nature of either the “biologically active conformation” or the
“toxic surface” remains elusive. Many previous studies suggest that the hydrophobic
structures are potentially able to disrupt cell membrane, resulting in substantial cellular
dysfunctions7, 41. Whether or not hydrophobicity is directly related to toxicity is still a
matter of debate. In the present study, toxicity observed in four out of five toxic lysozyme
aggregates (lysozyme_I, II, III, IV, VII) showed a positive correlation to hydrophobicity
(Figure 5.2, 5.4). However, the most hydrophobic species in lysozyme_VII and all the
BSA samples were not the most toxic ones (Figure 5.3 and 5.4). Evidence can also be
found in Hyp-F oligomers, where the structure with lower degree of hydrophobic packing
were able to interact strongly with cell membranes, penetrate into cells, and resulted in
high toxicity40. The authors suggest that the toxicity may arise due to the structural
flexibility40, 42. This hypothesis is actually in line with our finding in lysozyme aggregates,
that all the toxic structures showed high bis-ANS fluorescence compared with native
monomers. From that point, toxicity could possibly resulted from the increased flexibility
of the protein/peptide aggregates36.

156

Among the results discussed above, we noticed that under many conditions, both the
intermediates and mature aggregate structures caused low cell viability in MTS assay. To
further understand the difference between these structures, the toxic structure selected by
MTS assay were then tested using LDH and DCF assays, which determine cytotoxicity
and the respiratory burst activity in cells, respectively. Release of the cytosolic enzyme
lactate dehydrogenase (LDH) is known as an indicator of membrane leaking, a
consequence of cell death. It is noticeable that only in BSA_III and IV, the mature
structures are more toxic (Figure 5.5). In most of the tested samples, the intermediates
showed higher toxicity than the mature structure, although they exhibited similar effect
on cell viability (MTS) assay (Figure 5.5). This suggests that the intermediates exhibit
higher cytotoxicity. The non-polar compound 2',7'-dichlorofluorescin diacetate (DCFHDA) can penetrate the cell membrane, and be hydrolyzed by the intracellular esterase to
2',7'-dichlorofluorescin (DCFH). In the presence of reactive oxygen species (ROS),
DCFH can be oxidized into the highly fluorescent 2',7'-dichlorofluorescein (DCF)32.
Therefore, the DCF assay is widely used to measure the amount of intracellular ROS
level32, 33, 43. Increases in the ROS species indicates increased cellular stress. In general,
DCF results of the selected toxic structures followed similar trend to LDH measurements
(Figure 5.5), suggesting that the cytotoxicity may arise as a result of increased oxidative
stress inside the cell. Overall, the parallel comparison of these different assays suggest
that both intermediates and mature aggregates in protein aggregation process can affect
cell proliferation, but the intermediates generally exhibit higher cytotoxicity, probably
due to increased ROS in the cell. This also has the implication that different pathways for
cytotoxicity may be activated depending on the nature of aggregates.
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Figure 5.5. The toxicity of different protein aggregates were compared by MTS
assay, LDH assay, and DCF assay. In each assay, SH-SY5Y cells were incubated with 15
μM of selected aggregate samples. In MTS assay and DCF assay, data was normalized
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based on cell-only control. In LDH assay, max LDH release was set as 1, and all other
data was normalized accordingly. Error bars = ± S.D.
Here in this study, the most toxic species were found at 2 h or 12 h incubations,
which are flexible intermediate structures. This observation of toxic intermediates is in
agreement with the hypothesis that toxicity is related to protein’s flexibility as mentioned
above. Alternatively, toxicity is also proposed as a consequence of the dynamics of
protein aggregation process1, 20, 44, 45. Studies of amyloid β peptide have shown strong
correlations between toxicity and the free monomers or aggregation seeds, rather than
mature amyloid fibrils1. Considering the toxic intermediates observed in the present study
and reported in the literature, the toxicity may also relate to the ongoing aggregation
process and heterogeneous character of natural aggregates37. Although this hypothesis of
aggregation dynamics associated toxicity is able to explain many of the available
observation in the field, its mechanism is even more difficult to understand. Future work
on identifications of the diverse structures during aggregation process would be necessary.
Comparing and contrasting the toxic structures observed in vitro and in vivo may also
provide important insights for the actual toxic mechanism of protein aggregation.
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Figure 5.6. The initial conformational change during aggregation is a common key
factor to different protein aggregates observed in this study. However, toxicity was
observed in both types of intermediates that form amyloid and granular aggregates.
Further precisely structure analysis is needed to full distinguish different aggregation
intermediates in terms of toxicity.

5.4 Conclusion
In this study, different aggregate structures of lysozyme and BSA were generated,
and compared for hydrophobicity, structural flexibility, and cytotoxicity. Results showed
that aggregates in similar morphology could be differentiated on the biophysical
properties and related cellular effects, which provide evidence of heterogeneous
population of protein aggregates. In both lysozyme and BSA, cytotoxicity could arise as a
consequence of structural flexibility. The aggregates that formed rapidly and had no
significant conformational change from the protein native structure are essentially
harmless to the cells. To further precisely define the toxic conformation of proteins,
future work with high resolution structural identification would be needed.
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6.1 Introduction
Intracellular pH is essential to regulate many important behaviors of a cell such as
cell volume, membrane polarity, proliferation and apoptosis, ion transport, enzyme
activity, and protein degradation1. The pH varies considerably among subcellular
compartments, ranging from 4.7 in lysosome to 8.0 in mitochondria. Changes of pH in
living cells affect cellular internalization pathways, as well as synaptic transmission and
signal cascades in the nervous system. Disruptive pH variations in organelles associate
with dysfunctions and are observed in pathophysiology of many diseases, such as
triggering cancer, stroke, and Alzheimer’s disease. For example, the organelle lysosome
maintains an acidic environment (pH 4.5–5.5) that serves to denature proteins or to
activate degradation enzymes. Abnormal lysosomal pH can cause lysosome malfunction,
accumulation of cell trashes, and even lysosomal storage diseases that can affect every
part of the human body2. Therefore, it is very important to monitor pH changes inside
living cells in order to investigate cellular functions that can provide insight into
physiological and pathological processes.
Intracellular pH is normally detected using NMR, microelectrodes, absorbance
spectroscopy, and fluorescence spectroscopy1. Compared with other methods,
fluorescence detection of intracellular pH is not only simple-to-operate and highly
sensitive, but also has advantages of excellent spatial and temporal observations2-4.
Fluorescence-based techniques such as fluorescence microscopy and flow cytometry can
provide high-resolution and high-throughput analysis, thus, they have been widely used
to investigate intact subcellular pH. However, among the large numbers of pH fluorescent
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probes, only a few have been applied inside living cells5-7. Most intracellular fluorescent
probes have used morpholine residues for the selective accumulation in the acidic
lysosomes, since the ionizable tertiary amine groups tend to be protonated in acidic
environments4. As a consequence of tertiary amine protonation in acidic lysosomes, the
photo-induced electron transfer (PET) from the tertiary amine to the probe fluorophores
is prohibited, resulting in enhancement of the probe fluorescence8-10. The potential
drawbacks of these fluorescent probes are that they have broad pH responses and
relatively high fluorescent background issue at pH 7.4. Recently, fluorescein and
rhodamine dyes were used in approaches to reduce the background fluorescent at pH
7.411-13. However, most fluorescent probes are still not soluble in aqueous solution, and
some probes can cause sever photo-damage to cells due to their short absorption and
emission wavelengths (< 600 nm)14-16. A series of rhodamine dye counterparts were
recently reported to sensitively detect lysosomal pH in live cells. These fluorescent
probes have near-infrared excitation and emission wavelengths with deep tissue light
penetration, low cytotoxicity, excellent photostability, as well as low background
fluorescence. However, they were still insoluble in aqueous solution17. Therefore, the
readily accessible near-infrared fluorescent probes that have good water solubility, large
dynamic range and high specificity are still a challenging task for near-infrared imaging,
especially for sensitive detection of lysosomal pH in living cells.
In this chapter, one uncommon morpholine based fluorescent probe 1 with
morpholine residues to BODIPY dyes will be introduced to sense abnormal, elevated
intracellular pH. The fluorescent probe 1 selectively displays high fluorescence with great
photostability in a basic condition, but exhibits very weak fluorescence in an acidic
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condition. In addition, fluorescent probe 1 has a long emission wavelength and a high
pKa near the physiological pH, which provide more advantages for live cell fluorescence
imaging. To further sensitively detect lysosomal pH changes, another group of nearinfrared BODIPY-based fluorescent probes, probes 2, 3, 4, was synthesized for lysosomal
pH detection. Piperazine moieties were attached to the fluorescent cores to manipulate
the fluorescent responses of the probes at different pH values. Fluorescent probes display
very weak fluorescence at basic and neutral pHs, while decreasing the pH significantly
enhances fluorescence intensity. These fluorescent probes have advantages such as high
photostability, sensitive and selective near-infrared imaging of lysosomal pH in living
cells. They have potential for intact in vivo imaging and deep tissue penetration without
auto-fluorescence and unintended cellular damage issues.

6.2 Materials and methods
Intracellular fluorescent probes 1 and lysosomal pH probes 2, 3, 4 were synthesized
by Jingtuo Zhang from Dr. Haiying Liu’s research group. Details of compound synthesis
and characterization could be found in the original publication2.
Optical measurements – All absorption and emission spectra were recorded as
previously described in chapter 2. In brief, 20 mM and 50 mM of citrate-phosphateborate buffers were used for pH dependency and photostability measurements of
intracellular and lysosomal fluorescent probes, respectively. Stock solutions of all the
probes are at 1.0 mM in DMSO (probes 2 and 3) or aqueous solution (probe 1 and 4). To
avoid the interference caused by metal-phosphate and metal-citrate binding interactions
(forming precipitates of divalent cation phosphate and forming complex of the metal170

citrate), 10 mM KHP buffer (pH 4.0) and 10 mM HEPES (pH 7.4) buffer were used for
selectivity measurements of fluorescent probes. The UV-Vis absorption spectra of
fluorescent probes 1, 2, 3, and 4 for pH dependency, selectivity, photostability and
solvent effect measurements were collected in the range from 300 to 800 nm with
increments of 1 nm. Their corresponding fluorescence spectra were collected at the
excitation wavelength of 580 nm for fluorescent probes 1, and 620 nm for probes 2, 3, 4.
The excitation and emission slit widths were set up to 3 nm.
Determination of pKa by fluorometric titration – The constants Ka of fluorescent
probes were determined in buffer solutions by fluorometric titration as a function of pH
using the fluorescence spectra. The expression of the steady-state fluorescence intensity F
as a function of the proton concentration has been extended for the case of an n: 1
complex between H+ and a fluorescent probe, which is expressed by the equation as
below:
𝐹𝐹 =

𝐹𝐹𝑚𝑚𝑚𝑚𝑚𝑚 [H+ ]𝑛𝑛 + 𝐹𝐹𝑚𝑚𝑚𝑚𝑚𝑚 𝐾𝐾𝑎𝑎
𝐾𝐾𝑎𝑎 + [H+ ]𝑛𝑛

Fmin and Fmax stand for the fluorescence intensities at maximal and minimal H+
concentrations, respectively, and n is apparent stoichiometry of H+ binding to the probe
which affects the fluorescent change. Nonlinear fitting of the above equation to the
fluorescence titration data recoded as a function of H+ concentration with Ka and n as
free adjustable parameters yields the estimated apparent constant of Ka.
Live cell fluorescence imaging – Breast cancer cells MDA-MB-231 and normal
endothelial cells HUVEC-C (from ATCC) were cultured as previously described in
chapter 2. In brief, cells were plated on 12-well culture plates at 1 × 105 cells per well and
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incubated at 37 oC in a 5% CO2 incubator overnight. The next day, the medium was
removed and cells were rinsed twice with 1X PBS, after which fresh serum-free medium
was added and cells were incubated for 2 h at 37 oC in a CO2 incubator. Following 2 h
serum starvation, fresh serum free media with/without indicated concentrations of probes
and co-stains were added and incubated further with cells for 2 h. Cells were washed with
fresh serum free media without any fluorescence dyes to remove background
fluorescence. To adjust the intracellular pH, cells were treated with nigericin (5 mg mL-1)
in 2 mL potassium rich PBS at different pH values and incubated further for 15 min. Live
cell images were acquired using an inverted fluorescence microscope (AMF-4306,
EVOSfl, AMG) with DAPI filter for Hoechst 33342 (Sigma-Aldrich), GFP filter for
LysoSensor Green DND-189 (Invitrogen), and CY5 filter for fluorescent probes 1, 2, 3,
and 4. The fluorescence images were obtained at 40X and 60X magnification for
HUVEC-C and at 60X magnification for MDA-MB-231 cells. The exposure times for
each filter were kept constant. Co-localization analysis based on Pearson's coefficient
was done using JACoP plugin from ImageJ.35
Determination of cellular uptake efficiency – HUVEC-C cells were plated at a
density of 1 × 104 cells per well on a 96-well cell culture plate and incubated at 37 oC in a
5% CO2 incubator overnight. The next day, the culture media was removed and cells
were rinsed twice with PBS (pH 7.4). Fresh 100 mL media with indicated concentrations
of probes were added to the wells in triplicate and incubated for 2 h. Controls and blanks
were also set in triplicate at the same time. Controls had culture media and dyes but no
cells. Blanks used for background subtraction had cells and media but no dyes. After 2 h
incubation, the media (100 mL) was pipetted out from the plate and put in a fresh 96-well
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plate. Each well was rinsed with 100 mL of fresh PBS (pH 7.4), and the solution was
added to the respective wells in the fresh 96-well plate. Then the absorbance of the wells
was measured by an ELISA plate reader (BioTek Instruments, Inc.) at 712 nm, 710 nm,
and 687 nm (absorbance peaks of fluorescent probes 2, 3, or 4, respectively). The values
of the respective blanks were subtracted from samples (Adye) and controls (Actrl).
Cellular uptake efficiency was calculated as [1 – (Adye/Actrl)] × 100%.
Cell viability (MTS) assay – MTS assay was performed with MDA-MB-231 cells
and HUVEC-C cells (ATCC), as previously described in chapter 2. Briefly, the cells were
plated at a density of 5,000 cells per well on a 96-well cell culture plate and incubated at
37 oC in a 5% CO2 incubator overnight. The next day, media were removed and the cells
were washed with 1X PBS. Fresh media with 0-50 μM of fluorescent probes in DMSO
(with <0.5% DMSO final concentration in media) were added to the wells and measured
in 6 replicates for each dye concentration. Blanks that had everything else except the cells
were prepared at the same time. The plates were incubated at 37 oC in a 5% CO2
incubator for 72 h. After incubation, 20 μL of MTS reagent (CellTiter 96 Aqueous NonRadioactive Cell proliferation Assay (MTS) kit, Promega) was added to each well. The
absorbance at 490 nm was acquired after a 4 h incubation at 37 oC, using an ELISA plate
reader (BioTek Instruments, Inc.). Plots were normalized to control wells containing
media and cells only.
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6.3 Results and discussion
6.3.1

Intracellular pH probe

The intracellular pH probe 1 (Figure 6.1) was synthesized by Dr. Haiying Liu’s
group. The tri-(ethylene glycol) methyl ether groups were introduced to the meso-phenyl
rings and 1,7-positions of BODIPY dye, which enhances the solubility of probe 1 in polar
solvents. The functionalizing groups, morpholine moieties, were attached to the BODIPY
core at 4,4’-positions. The probe displays negligible change in absorption at different pHs
(data not shown). However, a fluorescence turn-on behavior was observed at basic pH,
with 14.3-fold enhancement of fluorescence intensity from pH 3.02 to 9.49 (Figure 6.1).
Theoretical modeling results showed that the fluorescent probe responded to pH via a
modulation of d-PET (photo-induced electron transfer) mechanism (Figure 6.2). At high
pH, the calculated HOMO and LUMO energies of morpholine moieties are lower and
higher than those of probe 1, respectively. This suggests that the electrons cannot transfer
from mopholine moieties to the probe core, leading to a prohibited a-PET mechanism and
high fluorescence of probe 1. Whereas at low pH, the protonation of morpholine moiety
results in a dramatic decrease of HOMO and LUMO energies, where the LUMO energy
of protonated morpholine moieties lies between the HOMO and LUMO energies of probe
1 (Figure 6.2). In this case, morpholine residues serve as electron accepters, which
quenched the fluorescence of the BODIPY dye via d-PET mechanism. In addition, probe
1 has a pKa value of 6.15, with maxima fluorescence increase lies in pH range 4.5-7.4,
showing great potential to sensitively detect changes near physiological pH. Moreover,
the deep-red emission prevents photo-damage to the cells, and the large Stokes shift
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(from 550 nm excitation to 665 nm emission at pH 7.4, figure 6.1) minimizes the
potential interference from excitation signals.

Figure 6.1. Chemical structure and fluorescence spectra of fluorescent probe 1 (5
μM) in buffer solution at different pH (with 1% DMSO). The corresponding curve shows
the increase of fluorescence intensity when pH increases.
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Figure 6.2. The HOMO and LUMO energies of fluorescent probe 1 and morpholine
moiety (N-methylmopholine, before and after protonation) were calculated.
Live cell fluorescence imaging of probe 1 was performed using HUVEC-C cells at
different intracellular pH values (Figure 6.3, 6.4). Since the tertiary amines of the
morpholine moieties tend to accumulate in acidic environments, we hypothesis that the
fluorescent probe 1 may label lysosomes in the cell. Therefore, a well-known commercial
lysosome probe, LysoSensor Green DND-189, was selected as a co-stain. Figure 6.3
shows that probe 1 exhibited very weak fluorescence signals at 5-25 uM. Slight
fluorescence enhancements could be observed with increased probe concentrations. The
merged fluorescence images show more green areas around the nucleus and only a few
green-yellowish dot structures can be observed by a careful examination (Figure 6.3).
However, the calculated Pearson’s coefficients of red (fluorescent probe 1) and green
(LysoSensor Green) channels are 0.92, 0.85 and 0.88 for 5 µM, 15 µM and 25 µM probe
1, respectively (Figure 6.3 cytofluorograms), indicating that the area stained by probe 1
matches those stained by LysoSensor Green in cells. This confirmed our hypothesis that
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fluorescent probe 1 mainly stained lysosomes or other acidic organelles in cells.
Therefore, the weak fluorescence of fluorescent probe 1 observed in the cells is a
consequence of fluorescence quenching by the protonated morpholine moieties via a dPET effect at lysosomal pH (4.5-5.5). In order to examine the fluorescence responses of
fluorescent probe 1 to different pHs inside of cells, we further adjusted the intracellular
pH of HUVEC-C cells using a widely used H+/K+ ionophore, nigericin, in K+ rich PBS
buffer solutions at pH 5.5, 6.5, 7.5, or 8.5 by equilibrating the intracellular and
extracellular pHs. At all three concentrations, fluorescent probe 1 displayed very weak
fluorescence at acidic pH (pH 5.5), whereas its fluorescence intensity showed gradual
enhancement as intracellular pH increased from 5.5 to 8.5 (Figure 6.4). In addition, at
each intracellular pH, higher probe concentration resulted in stronger fluorescence signals
(Figure 6.4). These responses of fluorescent probe 1 to increased intracellular pH are in
line with its optical responses to pH in buffer solutions (Figure 6.1), which further proved
the d-PET mechanism of fluorescent probe 1 at different pHs in live cells. However, the
commercial lysosome probe LysoSensor Green DND-189 did not exhibit any change in
fluorescence upon change of intracellular pH (Figure 6.4).
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Figure 6.3. Fluorescence images of HUVEC-C cells incubated with 5 μM, 15 μM, or
25 μM fluorescent probe 1. HUVEC-C cells were incubated with fluorescent probe 1 for
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2 h, post serum starvation (2 h) and imaged for co-localization with 1 μM LysoSensor
Green and (1 μg·mL−1) Hoechst 33342 stains. Images were acquired using the inverted
fluorescence microscope (AMF-4306, EVOSfl, AMG) at 40× magnification, scale bars =
100 μm. Cytofluorograms of green and red channel co-localization was carried out by
JACoP plugin of ImageJ.

Figure 6.4. Fluorescence images of HUVEC-C cells incubated with 5 μM, 15 μM, or
25 μM fluorescent probe 1 (red channel) and LysoSensor Green (green channel) in
buffers at different pH values of 5.5, 6.5, 7.5, or 8.5 having nigericin. Images were
acquired using the inverted fluorescence microscope (AMF-4306, EVOSfl, AMG) at 40×
magnification, scale bars = 100 μm.
We also investigated the toxicity of fluorescent probe 1 to HUVEC-C cells using
MTS assay (Figure 6.5). At a low concentration, 5 µM, the fluorescent probe 1 provided
more than 80% cell viability, when the concentration increased to 15 µM, the cell
viability dropped to 60-70%, indicating the low to moderate toxicity of fluorescent probe
1 to the cells in this concentration range. However, fluorescent probe 1 at higher
concentrations like 25 µM and 50 µM were very toxic to the cells as less than 10% cell
viabilities were observed.
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Figure 6.5. Effects of fluorescent probe 1 on cell proliferation measured by MTS
assay. HUVEC-C cells were incubated with 5 μM, 15 μM, 25 μM, or 50 μM of
fluorescent probe 1 for 48 h. To this 20 μL of MTS reagent was added per well and
absorbance at 490 nm was measured to determine cell viability. Error bars indicate ± SD.
6.3.2

Lysosomal pH probe

To further specifically target lysosome in the cells, piperazine moieties were
conjugated at 3,5-positions of BODIPY core to prepare the BODIY-based near-infrared
fluorescent probe 2 (Figure 6.6). However, the fluorescent probe 2 is hydrophobic and
displays less than 0.1 mg/mL solubility in water. In order to facilitate the interactions of
the probe with water molecules, the hydrophilic oligo(ethylene glycol)methyl ether
residues were attached to meso- and 3,5-positions, resulting in probes 3 and 4 (Figure
6.6).
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Figure 6.6. Chemical structures of fluorescent probes 2, 3, 4.
In organic solvents such as ethanol, dichloromethane, and DMSO, fluorescent probe
2 displays absorption and emission peaks at 668 nm and 715 nm, respectively, due to the
enhanced π-conjugation and intramolecular charge transfer (ICT) effect from piperazine
moieties at 3,5-positions to the BODIPY core. However, in pH 7.4 buffer, probe 2
showed increased tendency of self-assembly, decreased fluorescence, and shifted
absorption and emission peaks at 712 nm and 770 nm, caused by its hydrophobicity and
the ICT effect in polar solution. Compared with fluorescence of probe 2, probe 3 exhibits
181

similar optical properties in organic solvents, but blue-shifted absorption peak (710 nm)
and emission peak (755 nm) in buffer solution (pH 7.4), which may be attributed to the
reduced aggregation in aqueous solution with hydrophilic oligo(ethylene glycol)methyl
ether residues. Fluorescent probe 4 has the highest water solubility, significant extended
π-conjugation, and ICT effect from piperazine moieties to the BODIPY core, which
shows absorption peaks at 669 nm and 687 nm, and emission peaks at 720 nm and 750
nm in ethanol and buffer solution (pH 7.4), respectively. In addition, the highly watersoluble character of probe 4 further reduced its self-aggregation effect in buffer solution.
On the other hand, all three fluorescent probes display very sensitive fluorescence
responses to pH changes (Fig. 6.7). From pH 9.98 to 2.20, fluorescence enhancements of
75-, 88- and 102-fold were observed at 715 nm of fluorescent for probes 2, 3 and 4,
respectively (Fig. 6.7). In addition, there are significant blue shifts of 55 nm, 41 nm and
35 nm in emission spectra of the probes 2, 3 and 4, respectively. This is because in acidic
conditions, probe aggregation was reduced, and the nitrogen atoms in piperazine moieties
were protonated, which reduced the ICT effect from piperazine moieties to BODIPY
cores (Figure 6.6). Besides the ICT effect, potential PET effect from the lower nitrogen
atoms of the piperazine moieties may also contribute to the extremely low fluorescence
of all three probes in neutral/basic conditions. While at low pH, this potential PET
quenching effect could be reduced via the protonation of piperazine moieties. Therefore,
in basic to neutral pH range, all probes showed very weak fluorescence without any
evident changes, whereas fluorescence intensities gradually increased from pH 7.0 to
2.2(Figure 6.7). However, highly acidic pHs from 2.20 to 1.01 significantly quenched
fluorescence of the probes (Figure 6.7). More evidences are needed to fully understand
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the fluorescence quenching mechanism of these probes at extremely low pH. The pKa
values of probes 2, 3 and 4 are 2.91, 3.19 and 3.57, respectively. It is very clear that
probe 4 exhibits the highest fluorescence responses with the highest pKa value among all
three probes, since this highly water-soluble probe has less aggregation, and is protonated
considerably more easily in aqueous solution. As a consequence, probe 4 showed higher
sensitivity to pH than probes 2 and 3. Linear fluorescence responses to pH were shown
between physiological pH (~7.4) and lysosomal pH (~4.2), where probe 4 displayed the
highest sensitivity (Figure 6.7). The linear, high dynamic range, and sensitive responses
of the probes to pH indicate the feasibility of intracellular pH detection.
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Figure 6.7. Emission spectra of fluorescent probes 2, 3 and 4 (5 mM) were collected
in buffer solution at pH 2.20-9.98.
Live cell imaging in various concentrations of all three probes were conducted using
MDA-MB-231 cells and HUVEC-C cells (Figure 6.8, 6.9). In both cancer and normal
cells, probes 2, 3, and 4 showed fluorescent signals, and the area in the cell that stained
by probe 2, 3, or 4 (red channels in Figure 6.8, 6.9) matched those stained by LysoSensor
Green (green channels in Figure 6.8, 6.9). The co-localization Pearson’s coefficients are
8.5-9.4. Therefore, these probes are able to target lysosomes or other acidic cellular
compartments in cells. Interestingly, the highly water soluble probe 4, which fluorescent
the strongest in buffers, displayed the weakest fluorescent signals inside cells. Whereas
the most hydrophobic one, probe 2, showed the highest fluorescent intensity among all
three probes and displayed good signal even at 2 µM concentration (data not shown). A
possible reason could be that probes 2 and 3 are more hydrophobic and less stericly
hindered than probe 4, which could interact with the hydrophobic lipophilic membrane
structures, thus, the fluorescence was activated by depressing ICT effect of the
fluorophores18. On the other hand, probe 4 showed the lowest cytotoxicity after 72 h
incubation with cells (Figure 6.10 A). While probe 2 is the most harmful to the cells,
resulting in only ~50% viability at 5 µM and less than 10% viability at 15 µM and higher
concentration (Figure 6.10 A). Probes 3 and 4 showed very mild toxicity with greater
than 70% cell viability even at 50 µM concentration (Figure 6.10 A).
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Figure 6.8. Live cell fluorescence images of probes 2, 3, and 4 in MDA-MB-231
cells. Cells incubated with 5 µM of respective probes for 2 h, post serum starvation (2 h)
and imaged for co-localization with 1 µM LysoSensor Green and (1 μg/mL) Hoechst
33342 stains. All images were acquired at 60X magnification using inverted fluorescence
microscope (AMF-4306, EVOSfl, AMG).

Figure 6.9. Live cell fluorescence images of probes 2, 3, and 4 in HUVEC-C cells.
Cells were incubated with 5 µM of respective probes for 2 h, post serum starvation (2 h)
and imaged for co-localization with 1 µM LysoSensor Green and (1 μg/mL) Hoechst
33342 stains. Images were acquired using the using inverted fluorescence microscope
(AMF-4306, EVOSfl, AMG) at 60X magnification.
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To understand the differences of fluorescence responses in buffers and in cells,
cellular uptake efficiency of the three probes was measured using HUVEC-C cells
(Figure 6.10 B). We found that probe 2 has much higher cellular uptake efficiency (more
than 30%) at all three concentrations compared with probes 3 and 4. Probe 3 has
moderate cellular uptake efficiency (18%) at 5 μM, but there are only 8% and 4% of
probe 3 were taken by the cells at 15 μM and 25 μM, respectively. In case of probe 4, the
cellular uptake efficiencies were only 10%, 3% and 3% for incubation concentration of 5
μM, 15 μM and 25 μM, respectively. This low cellular uptake of probe 4 could be
concluded as the main reason for its relatively weak intracellular fluorescence signals.

Figure 6.10. The cytotoxicity (A) and cellular uptake efficiency (B) of probes 2, 3
and 4 at different concentrations. (A) Cytotoxicity and cell proliferation effect of were
tested by MTS assay. The MDA-MB-231 cells were incubated with 5-50 μM of probes 2,
3 and 4 for 72 h and cell viability was measured by adding MTS reagent and measuring
the formation of formazon at 490 nm. Error bars indicate ± S.D. (B) The cellular uptake
efficiency was calculated as the percentage of probe taken up by cells out of total amount
of probe in initial incubation solution.
We have further examined the pH dependency of the probes inside the living cells.
The intracellular pH of HUVEC-C cells were adjusted using nigericin (5 μg mL-1) in pH
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5.0, 5.5, 6.0, and 7.5 buffer solutions18-20. Even though probe 4 exhibited very weak
fluorescence in cells near physiological pH (pH 7.5), its fluorescence intensity was
significantly enhanced as the intracellular pH decreased to 5.0 (Figure 6.11). This turn-on
response of probe 4 to acidic intracellular pH indicates that it is sensitive to pH inside the
living cells, following the same ICT and potential PET mechanisms as previously
described. In addition, commercial probe LysoSensor Green did not display any obvious
change of fluorescence to pH changes. Probes 2 and 3 displayed similar but less
fluorescence enhancements when the intracellular pH decreased from 7.5 to 5.0 (data not
shown). This difference may be due to the fact that probe 4 has higher pKa value and
better water solubility than probes 2 and 3.

Figure 6.11. Fluorescence images of HUVEC-C cells incubated with 15 µM probe 4
at different pH values. 1 µM LysoSensor Green and 1 μg/mL Hoechst 33342 were used
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as co-stains. Images were acquired using the using inverted fluorescence microscope
(AMF-4306, EVOSfl, AMG) at 40X magnification.

6.4 Conclusion
Based on modulation of ICT and/or PET mechanisms of the functionalizing groups
to the fluorescent BODIPY core, four intracellular fluorescent probes were prepared,
showing distinct responses to pH changes. The pH sensitive morpholine-functionalized
fluorescent probe 1 displays unusual fluorescence turn-on response at basic pH in
aqueous solutions, and quenched fluorescence in acidic condition via the d-PET effect
from protonated morpholine moieties to the BODIPY cores. Whereas the lysosomal pH
probes 2, 3, and 4 display extremely low fluorescent at neutral pH due to ICT and
potential PET effects from the piperazine moieties to BODIPY cores, and become highly
fluorescent at low pHs. All four probes are photostable, cell-permeable, and showed a
potential non-invasive method with deep-red fluorescence and low background for
monitoring intracellular/lysosomal pH changes inside of living cells.
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Chapter 7 Summary and perspectives
In the field of protein folding and aggregation, considerable process has been made
in characterization of the native proteins and the amyloid fibrils. However, our
knowledge of amorphous aggregates is still very limit, although they have been
constantly observed in protein aggregation and disease processes. In this dissertation, we
have focused on characterizing the amorphous aggregates formed from two globular
proteins (lysozyme and BSA) and one intrinsically disordered peptide (Aβ). Among these
lysozyme and Aβ have been linked to human amyloid diseases. Two types of
posttranslational modifications, disulfide bonding and side-chain acetylation, were
demonstrated to alter the morphologies of protein aggregates. In addition, diverse
amorphous aggregates using literature reported conditions were also prepared to
investigate the relationship between aggregate structure and cytotoxicity.
In chapter 3, the scrambling of disulfide bonds in lysozyme and BSA were observed
in aggregation of these proteins at condition close to physiological. Even though both
protein aggregates were amorphous in morphology, the two structures are very distinct in
terms of size, shape, flexibility and surface hydrophobicity as reflected by spectral
characteristics. The differences between the two types of structures may be a
consequence of protein size, reduction level, and the structure properties of the local
environment near disulfide bonds. Since lysozyme is an amyloidogenic protein while
BSA is not, observations of aggregates from these two different types of proteins could
give insight into the aggregation pathways that may be relevant for several other globular
proteins.
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In chapter 4, we blocked the positive charge on the two lysine residues of Aβ peptide,
K16 and K28 by acetylation. Interestingly, only acetylation on K16 was able to affect
molecular property and amyloid formation of Aβ. Acetylation on K16 position can
significantly increase the hydrophobicity of residues 16-21, which consequently disrupts
the amyloid fibril formation. Whereas, the peptides with single acetylation on K28 can
still assemble into typical amyloid fibrils and were confirmed by ThT fluorescence and
SEM images. Furthermore, the amorphous aggregates formed from heterogeneous
mixtures of WT and acetylated peptides exhibit severe cytotoxicity to SH-SY5Y cells,
indicating the heterogeneity of aggregates may be central to cellular toxicity.
After generating diverse amorphous aggregates as pet reported literature that are
different in size, morphology, and cytotoxicity, we noticed that many amorphous
structures were subtly different. We have generated eleven different aggregates from two
proteins, lysozyme and BSA. Thees aggregates varied in morphology, size, flexibility,
and hydrophobicity. The aggregates were then compared for surface hydrophobicity,
structural flexibility, and cytotoxicity, which provide evidence of heterogeneous
population of protein aggregates being critical for cytotoxicity. We observed that the
conformational changes of native monomer that occur in the early stage of aggregation
process is essential for toxicity. Most toxic species are structurally flexible, however, no
clear correlation was found between cytotoxicity and extent of hydrophobicity. Therefore,
the observed cytotoxicity of different structures may result from the heterogeneous
dynamics of the aggregation process.
We are also facing problems similar to many research groups focusing on protein
aggregation: overlapping biochemical/biophysical properties of the protein aggregates
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generated under different conditions were observed with no clear correlations to
cytotoxicity. To have a better understanding of protein aggregation and its relationship to
cellular toxicity, we need to first, develop high resolution structure analysis techniques of
protein aggregates. Recently, the aggregation intermediates or oligomers are recognized
as the major toxic species. But these structures are usually highly unstable, which cannot
be analyzed using traditional X-Ray crystallography or NMR methods. Fluorescent
probes used in our research are sensitive to certain properties, but still not able to provide
precise description of the structure. Some conformation specific antibodies that have been
developed from in vivo samples are applied in detection of amyloid structure, but these
antibodies were not suitable in detection of smaller oligomers or other species. Another
problem in the field is the disconnection between in vitro and in vivo studies. Although
with the help of modern technology, people can prepare almost all kinds of protein
aggregates in the laboratory, the ultimate goal is to understand the in vivo disease process.
In vivo proteins have higher level of heterogeneousness and posttranslational
modifications that are absent in vitro. This is also why we have performed acetylation
study of Aβ peptide in chapter 4. In addition, the nature of many naturally derived protein
assemblies still remains unclear. Although more work is needed, this dissertation research
is a step in the direction to correlate different structural aggregates generated from same
protein to cellular toxicities.
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Appendix A

Supporting Information for Chapter 4

Table A1. The top 10 most stable ANS-WT Aβ42 complexes analyzed by AutoDock
Vina and DSX (scores in kcal/mol).
Vina

Main Interacting

Vina

Ranking

Residues

Score

1

10 and 14

2

Zvina

DSX Score

Zdsx

-6.1

-2.48

-12.386

-1.120

10 and 14

-5.5

-0.91

-8.264

-0.301

3

40-42

-5.2

-0.13

-1.975

0.950

4

10 and 14

-5.1

0.13

-6.066

0.137

5

40-42

-5.0

0.39

-1.402

1.064

6

40-42

-5.0

0.39

-8.916

-0.430

7

40-42

-4.9

0.65

-7.941

-0.236

8

40-42

-4.9

0.65

1.946

1.730

9

40-42

-4.9

0.65

-8.171

-0.282

10

17 and 18

-4.9

0.65

-14.353

-1.512
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Table A2. The top 10 most stable ANS-K16Ac Aβ42 complexes analyzed by
AutoDock Vina and DSX (scores in kcal/mol).
Vina

Main Interacting

Ranking

Residues

1

10 and 14

-6.1

-1.958

-12.311

-1.740

2

10 and 14

-5.5

-0.636

-8.049

-0.519

3

10

-5.5

-0.636

-9.119

-0.826

4

10

-5.2

0.024

-5.428

0.231

5

31

-5.2

0.024

-3.362

0.822

6

10 and 14

-5.1

0.245

-6.244

-0.003

7

15 and 19

-5.0

0.465

-3.56

0.766

8

15 and 19

-4.7

1.126

-7.425

-0.341

9

19

-4.6

1.346

-0.612

1.610

Vina Score
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Zvina

DSX Score

Zdsx

Table A3. The top 10 most stable ANS-K28Ac Aβ42 complexes analyzed by
AutoDock Vina and DSX (scores in kcal/mol).
Vina

Main Interacting

Ranking

Residues

1

Vina Score

Zvina

DSX Score

Zdsx

10 and 14

-6.1

-2.041

-12.312

-1.390

2

10

-5.5

-0.816

-8.888

-0.777

3

10 and 14

-5.3

-0.408

-2.478

0.371

4

40-42

-5.2

-0.204

-2.234

0.415

5

40-42

-5.0

0.204

-0.274

0.766

6

17 and 18

-4.9

0.408

-13.65

-1.629

7

40-42

-4.7

0.816

-1.474

0.551

8

15

-4.6

1.021

-1.478

0.550

9

40-42

-4.6

1.021

1.838

1.144
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Table A4. The top 10 most stable ANS-KKAc Aβ42 complexes analyzed by
AutoDock Vina and DSX (scores in kcal/mol).
Vina

Main Interacting

Ranking

Residues

1

Vina Score

Zvina

DSX Score

Zdsx

10 and 14

-6.1

-2.179

-12.339

-1.468

2

10 and 14

-5.5

-0.567

-8.092

-0.446

3

10

-5.5

-0.567

-9.018

-0.669

4

10 and 14

-5.3

-0.030

-5.683

0.133

5

40-42

-5.2

0.239

-2.514

0.896

6

40-42

-5.1

0.507

-9.67

-0.826

7

40-42

-5

0.776

-0.645

1.345

8

40-42

-5

0.776

-7.496

-0.303

9

19

-4.9

1.045

-0.672

1.339
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Figure A1. Fibrillation/aggregation of WT and acetylation modified peptides in the
first 5 hours was monitored by ThT. Ten μM of peptide samples were incubates with 10
μM of ThT. Fluorescence emission spectra was collected at 460-700 nm with excitation
at 450 nm. Peak intensities at 487 nm were plotted in function of time. SEM images of
samples after 5 hours of incubation. Scale bars are 10 μm and 5 μm for top panel and
bottom panel, respectively.
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MTS assay of SH-SY5Y cells with 1 uM samples
1.2
1
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0.6
0.4
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KK Ac
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MTS assay of SH-SY5Y cells with 5 uM samples
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1
0.8
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WT:K16Ac WT:K28Ac WT:KKAc

7d

Figure A2. Cell viability of SH-SY5Y cells with Aβ42 fibrils or aggregates. The free
Aβ42 or acetylation modified Aβ42 peptides were incubated at pH 7.4 and 37 oC for 0 h,
72 h, or 7 d, and then added to SH-SY5Y cells to a final concentration of 1 or 5 μM. Cell
proliferation were measured after 48 h incubation with samples by taking absorbance at
490 nm. Error bars = ± S.D.
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Figure A3. Atomic models of U-shape Aβ42 fibrils (2BEG) and Aβ40 fibrils
(2LMN and 2M4J). The two lysine residues K16 and K28 are shown in red stick
structures. In fibril model 2BEG, the disordered first 16 N-terminal residues are omitted.
The structures were generated using USCF Chimera.
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Appendix B

Supporting Information for Chapter 5

Table B1. Sample preparation conditions of all the 17 lysozyme and BSA
samples
Sample #

structure

1

Amyloid

2 & 12

3&4

5-6

Amorphous
aggregates

Amorphous
aggregates

Amorphous
aggregates

condition
Samples contain 1 mM lysozyme in HCl solution (pH 2.0)
were incubated at 65 oC for 7 days1
Samples contain 40 μM lysozyme (#2) or BSA (#12) in
phosphate buffer (pH 7.2, 20 mM, with 150 mM NaCl)
were incubated at 37 oC for 7 days2
Samples contain 699 μM lysozyme in Phosphate buffer
(pH 7.4, 100 mM) were incubated at 56 oC (#3) and 25 oC
(#4) 3
Samples contain 80 µM (#5) and 120 µM (#6) lysozyme
in Phosphate buffer (pH 7.0, 50 mM) were incubated at 25
o 4

C

Samples contain 40 µM (#7, #15), 80 µM (#8, #16) and
7-9

Amorphous

120 µM (#9, #17) lysozyme in Phosphate-NaOH buffer

15-17

aggregates

(pH 12.0, 50 mM) with 0M (#7-9) or 14 mM (#15-17) of
SDS were incubated at 25 oC4
Samples contain 100 µM BSA in glycine-HCl buffer (pH

10

Amyloid

3.0, 50 mM , with 50 mM NaCl) were incubated at 65 oC
for 4 h then followed by room temperature incubation for
30 days5

11

Amorphous

Samples contain 140 uM lysozyme in HCl solution (pH

aggregates

2.0, with 136.7 mM NaCl, 2.68 mM KCl, and 4 mM
201

DTT). Samples were first mixed via vortex and then
incubated were incubated at 55 oC for 30 days6
13

14

protofibrils

Samples contain 37.6 μM BSA in Tris–HCl buffer (pH
7.4, 20 mM) were incubated at 70 oC for 4 days7

Amorphous

Samples contain 7.5 uM BSA in phosphate buffer (pH

aggregates

8.9, 0.1 M) were incubated at 62 oC over 10 h8

202

Figure B1. SEM images of lysozyme_I, II, and III. Scale bars = 5 μm.

Figure B2. SEM images of BSA_I, II, III, and IV. Scale bars = 5 μm (for BSA_I, II,
and III) or 10 μm (for BSA_IV).
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Figure B3. SEM images of lysozyme_IV, V, IV and VII. Scale bars = 5 μm.
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